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Abstract
Indian pharmaceutical companies spend one-third of their revenue from supply chain
management (SCM) activities due to inherently poor transportation infrastructure. SCM
is a vital function for many companies, as it is usually employed to lower expenses and
increase sales for the company. SCM costs are higher in India than they are in other areas
of the world, amounting to 13% of India’s GDP. The purpose of this study was to explore
SCM strategies Indian business leaders in the pharmaceutical industry have used to
reduce the high costs associated with SCM. This study used a single case study research
design and semistructured interviews to collect data from 3 SCM business leaders
working in Indian pharmaceutical organizations and possessing successful experience in
using SCM strategies to reduce high costs. Goldratt’s (1990) theory of constraints was
used as the conceptual framework for this study to identify challenges associated with
SCM strategies. Data from semistructured interviews, observations, and company
documents were processed and analyzed using data source triangulation, grouping the
raw data into key themes. The following 3 themes emerged: distribution and logistics
challenges, impact of SCM processes, and best practices and solutions. The implications
for positive social change include the potential to reduce supply chain risk, which could
lead to lower product prices for consumers, increased stakeholder satisfaction, and a
higher standard of living.
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Section 1: Foundation of the Study
The pharmaceutical supply chains in developing and developed countries vary
interms of their organization, financing, function, and ideal characteristics of the best
performing supply chains (Choi, Narasimhan, & Kim, 2012). Supply chain management
(SCM) in the pharmaceutical industry can transform the organization to make better use
of assets and resources, to generate profits, to enhance shareholder value, and and to
positively respond to customer demand. Lack of effective SCM can cause problems for
organizations (Wisner, Tan, & Leong, 2015). The focus of this qualitative study is to
determine the best practices and successful SCM strategies that Indian business leaders in
the healthcare industry can use to reduce the costs associated with SCM.
Background of the Problem
The supply chain is the network created among different companies that produce,
handle, and distribute a specific product (Susarla & Karimi, 2012); in the current study,
the product being investigated is pharmaceutical medicine. The supply chain is essential
to getting medicine to market and generating revenue from the process. However, we
keep in third person do not understand the difficulties and challenges associated with this
supply chain in places such as India. There was a knowledge gap about effective SCM in
third world countries with a high incidence of medical need. In a global marketplace,
managing the supply chain was a significant challenge, because of continually changing
demands of shorter product lifecycles, industry consolidations, variable conditions on the
ground (Assey, 2012).
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SCM is vital for companies, as a successful SCM strategy can lower expenses and
increase sales for the company. SCM practices enable the world's leading organizations
to realign their supply chain to the distinct set of concepts by providing functioning
solutions for enterprise needs in supply and demand planning and forecasting, sourcing
and procurement, and supply chain execution (Susarla & Karimi, 2012). The connections
and nodes in a supply chain achieve functions that contribute to the value of the goods
transported through the chain (Assey, 2012). Any connection that does not work well
reduces the overall effectiveness of the whole supply chain (Assey, 2012). Effective and
efficient supply chain processes are vital to reduce the product cost while maintaining
quality and ensure the availability of inventory. To succeed, companies that distribute
medicine must practice effective SCM to ensure their competitiveness in the market.
Problem Statement
Indian pharmaceutical companies spend one-third of their revenue from SCM
activities due to inherently poor transportation infrastructure (PCGI, 2013; Tyagi &
Agarwal, 2014). SCM costs are higher in India than in other areas of the world,
amounting to 13% of India’s GDP (Adhikary & Bora, 2014). The general business
problem is that some Indian healthcare business organizations are spending a large
amount of money on SCM issues. The specific business problem is that some Indian
business leaders in the healthcare industry lack knowledge of strategies to reduce the high
costs associated with SCM.
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Purpose Statement
The purpose of this qualitative study was to explore the SCM strategies that
Indian business leaders in the healthcare industry have used to reduce the high costs
associated with SCM. I used a case study research design approach to explore the SCM
related problems in the distribution of pharmaceutical drugs in India. The sample
population consisted of three business leaders working in Indian healthcare organizations
that are successful in using SCM strategies to reduce the high costs. This population is
important because they are the key stakeholders who manage the SCM strategies. The
research design included the following data sources: (a) semistructured interviews, (b)
company documentation, and (c) observations. The social impact of this study was that
its results may enable leaders of healthcare business organizations to identify and
implement best practices in SCM processes, reduce operating costs, improve profitability,
and facilitate increased availability and distributions of medicines to patients.
Nature of the Study
Yin (2014) identified three methods of research: quantitative, qualitative, and
mixed methods. A quantitative method is used to determine the relationship between
variables through hypothesis testing and generalizability of results (Bhattacherjee, 2012).
Qualitative research is a form of research in which the researcher collects and interprets
the data, making the researcher as much a part of the research process as the participants
and the data they provide (Corbin & Strauss, 2014). The mixed-methods research
methodology combines qualitative and quantitative research methods (Yin, 2014).
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Qualitative research methodology develops an understanding of participants’
views and experiences (Montero-Marín, Carrasco, Roca, Serrano-Blanco, Gili, Mayoral,
& García-Campayo, 2013). For this reason, I selected the qualitative research design
method to identify distribution practices and transportation challenges that are
contributing to the healthcare companies' operational costs and accessibility at regional
centers in India. The quantitative method was not selected because my goal is not to test
hypotheses or the relationship of variables (Bishop & Lexchin, 2013). The
phenomenological research design approach is suitable for exploring the perceptions,
opinions, and feelings of participants based on their lived experiences with a particular
phenomenon (Moustakas, 1994). For this reason, I did not select a phenomenological
research approach.
The qualitative content analysis research approach is a research method for
subjective interpretation of the content of text data through the systematic classification
process of coding and identifying themes or patterns (Ji Young & Eun-Hee, 2014). As a
result, the content analysis research design approach was not suitable for my study. The
ethnography research design approach is a research approach used to investigate
unfamiliar cultures through close observation, reading, and interpretation (Hohmann &
Shear, 2014) and, consequently, it was not suitable for my study. The narrative analysis
research design focuses on the way in which people make and use stories to interpret the
problem. In addition, it focuses more on human knowledge views than collection and
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processing of data (Robert & Shenhav, 2014). For these reasons, I did not select a
narrative research design approach for my study.
In this study, I used a qualitative case study research approach to collect data
through semistructured telephone interviews via Skype with the SCM business leaders.
According to Yin (2014), the case study research design approach relies on the paradigm
of focusing on a bounded system to explore and explain knowledge and subjectivity of
respondents’ experiences while highlighting commonalities and differences.
Research Question
The general business problem was that Indian healthcare organizations are
spending a significant amount of their budgets on SCM related factors. The specific
business problem is that several Indian business leaders in the healthcare industry lack
knowledge of strategies that could be used to reduce the high costs associated with SCM.
The overarching research question in this study was as follows:
RQ1: What SCM strategies can Indian business leaders in the healthcare industry
use to reduce the high costs associated with SCM?
To provide conclusions, I documented the interviews of the three business leaders
in India who were successful in implementing best practices and SCM knowledge.
Interview Questions
I used semistructured interviews to explore supply chain distribution practices and
processes. I used semistructured interview questions allowed for open-ended responses
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while ensuring that interview sessions are guided to address the research questions of this
study (Marshall & Rossman, 2011). The interview questions included the following:
1. What is the process of medicine distribution in India?
2. What are the factors that contribute to the challenges of distributing medicine
in India?
3. What are logistic challenges encountered in distributing medicines in India?
4. What is the impact of distribution, disruptions, and logistic challenges to the
healthcare companies in India?
5. Do you think business leaders are spending considerable money in SCM
related factors? Why or why not?
6. How can SCM process reduce the costs of medicine in India?
7. What type of SCM practices are in place for distributing medicines in India?
8. What are the primary logistical challenges faced by medicine distributors in
India? Such as long distance travel of the medicines?
Conceptual Framework
Goldratt’s (1990) theory of constraints (TOC) was used as the framework for this
study. The TOC is a system-based management philosophy that seeks to understand and
identify the core causes that limit a system from achieving higher performance relation to
its goal (Goldratt, 1990). I used the TOC method to identify challenges asscoiated with
SCM strategies and to find solutions. The TOC paradigm states that every single firm
must have at least one constraint (Goldratt, 1990). A constraint is defined as an element
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or factor that limits the system from doing more of what it was designed to accomplish
(Goldratt, Cox & Whitford, 1992). The TOC encourages business managers to identify
what is preventing them from achieving their goals and to find solutions to overcome this
hindrance.
There are three distinct but interrelated areas in TOC: logistics, performance
measurement, and logical thinking (Cox & Spencer, 1997). TOC applications in the
logistics category include logistical challenges, scheduling method, and value-added tax
(VAT) analysis. Performance measurement determines whether the organization is
making money. Development of TOC incorporates solutions for SCM.
Definition of Terms
The unique operational terms used in the study are defined below.
Active pharmaceutical ingredient (API). An API is any component intended to
provide the pharmacological activity or another direct effect in the diagnosis, treatment,
or prevention of disease (General Definitions’ Rule, 1978).
Best practices. Best practices are procedures and practices implemented
throughout an organization to increase organizational competitiveness (Seeger, Locker, &
Jergen, 2011).
Supply chain management. SCM includes guidelines and best practices that are
evolved over time for effective management of the supply chain in order to gain
competitive advantage (Christopher & Holweg, 2011).
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Theory of supply and demand. An economic model of price determination in a
market, the theory concludes that the unit price for a particular good will vary until a
point is reached where the quantity demanded by customers equals the quantity supplied
by producers (Weeks, 2012).
Assumptions, Limitations, and Delimitations
In this section, the assumptions, limitations, and delimitations of the study are
presented.
Assumptions
Assumptions are notions that the researcher believes to be true and accurate (Elo,
Kaariainen, Kanste, Polkki, Utriainen, & Kyngas, 2014). The first assumption was that
the participants would answer the questions as honestly as possible and that the
participants would not drop out of the study. The second assumption was that the
participants selected would have the necessary expertise to provide relevant and valid
data. The third assumption was that a case study research design approach would be the
best design for this qualitative study. Finally, the last assumption was that the information
presented in this study would add to the SCM body of knowledge about successful
strategies and best practices.
Limitations
Limitations are potential shortcomings of the study that are typically out of
researcher’s control (Gibbons, 2015). The scope of this study was limited to SCM issues
and the availability of medicine in India, although its findings may be applicable to other
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markets. The study sample was limited to three business leaders working in India. The
results of this qualitative study depend on the participants’ abilities to articulate events
and for the researcher to document and interpret the information accurately.
The main limitations that affected this study were: the ability to generalize,
availability of information, the experience of the participants with taxonomies, and the
researcher’s training. Yin (2014) noted that researchers require training when conducting
the study research. To prepare for conducting this study, I completed several graduate
level research design courses, reading numerous peer-reviewed references, and reviewing
case study books.
Delimitations
Delimitations are design parameters which are within the control of the
researcher, such as the study site location (Marshall & Rossman, 2011). The scope of the
study was limited to three business leaders who have been successful in taking advantage
of the best practices and SCM knowledge working in India. Using a semistructured
interview format allowed me to elicit additional information from the study participants
by asking follow-up questions based on interviewees answers.
For the purpose of this study, I focused on preselected interview questions and
probed deeper into additional questions as the opportunity presented itself. My goal in
conducting this study was to explore and record the participants' experiences and
thoughts.
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Significance of the Study
The purpose of this qualitative case study was to explore the SCM strategies that
Indian business leaders in the healthcare industry have used to reduce the high costs
associated with SCM. In this section, the study's contribution to business practice and
implication for social change are presented and discussed.
Contribution to Business Practice
This research study was significant because it may enhance organizations' supply
chain effectiveness and their reputation for on-time delivery, reducing organizations'
operational costs. The purpose of this qualitative study was to explore the SCM strategies
that Indian business leaders have used in the healthcare industry to reduce the high costs
associated with SCM. Results of this study revealed the strengths and weaknesses of the
medicine supply chain in India, which the companies will benefit from because they can
maintain their strong points and improve on the weaknesses.
Implications for Social Change
This study may contribute to social change by assisting organizations in the field
of medicine in ensuring that essential medicines are available for patients at the time they
need them. The results of the study may change how patients view medical organizations
that are associated with providing medicines for their treatments.
The results of the study may also provide insights on how to ensure that medicine
is available for patients’ treatments. Moreover, the results of the study could change the
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manner in which patients purchase their medicines because supply chains may be able to
ensure the availability of medicines at all times.
A Review of the Professional and Academic Literature
SCM costs are higher in India than in other areas of the world, amounting to 13%
of India’s GDP (Adhikary & Bora, 2014). The purpose of this qualitative case study was
to explore the SCM strategies that Indian business leaders in the healthcare industry have
used to reduce the high costs associated with SCM.
The literature review covered the topics of SCM efficiency, distribution and
transportation logistics challenges, and demand forecasting methods that could assist
improving the SCM activities. The content under research represented the material from
recognized supply chain institutions, journals, and professionals include specific trends of
problem areas and solution across the industry. Additional literature obtained through
searching various journal articles, published books, and other credible publications found
online such as Thoreau, different ProQuest Dissertations and Theses, NCBI, Medline
Plus, EBSCOhost database, PubMed, Google Scholar, JSTOR, PsycINFO, Questia, Sage,
and others.
I have organized this section in several subsections, which are: (a) general
analysis of the supply chain distribution processes which will describe the supply chain
processes in India, (b) SCM challenges in the distribution of medicine in India which will
discuss the interruptions faced by supply chain organizations, (c) challenges in SCM
activities due to inherently poor transportation infrastructure and the transportation
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infrastructure and its impact on SCM activities, (d) demand forecasting methods that
could improve SCM activities in India, and (e) best SCM practices that are in place and
how they are used effectively in Indian healthcare companies. A conclusion and a
summary of the section followed these discussions.
Regarding the literature review search strategy used in this study, I used various
key terms and phrases in online databases and extracted key information relevant to the
study. The search for literature commenced with computerized databases such as
Thoreau, different ProQuest Dissertations and Theses, NCBI, Medline Plus, EBSCOhost
database, PubMed, Google Scholar, JSTOR, PsycINFO, Questia, Sage, and others. The
literature retrieval mechanisms contributed to the gathering of an informative collection
of studies. It further helped in the conceptualization of a framework that would include
relevant information about the medicine supply chain in India.
Search criteria included keywords and phrases, such as a pharmaceutical industry,
pharmaceutical supply chain, medicine supply chain, medicine supply chain in India,
importance of efficient supply chain distribution, developed & developing countries
supply chain, inventory management, regulatory system, interruptions in procurement,
improving medicine demand forecast method, reduce the transportation lead-time of
medicine distribution in India, and impact of supply chain best practices.
I referenced a total of 132 references in this study, out of which 124 are peer
reviewed, and 92% were published within five years of the expected date of receiving
Walden University’s Chief Academic Office (CAO) approval for graduation. Regarding
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the literature review section, 85% of sources used are peer reviewed and more than 60
peer-reviewed sources were referenced with a frequency of each limited to a maximum of
three times.
Theory of Constraints
Goldratt’s (1990) TOC was used in this study to frame organizational
performance. TOC provided a useful basis for this study because it encourages business
managers in the healthcare industry to identify challenges asscoiated with SCM strategies
and to find solutions to overcome those challenges. TOC framework is designed to
facilitate a systematic analysis within the demands of constraints. There are three distinct
but interrelated areas in TOC, including logistics, performance measurement, and logical
thinking (Cox & Spencer, 1997). The TOC encourages business managers to identify
what is preventing them from achieving their goals and to find solutions to overcome this
hindrance. The TOC framework provided a useful basis for this study because it
encourages business managers in the healthcare industry to identify solutions to reduce
the high costs associated with SCM.
In the TOC, the performance of processes and systems has a direct relation to the
performance of its constraint. Goldratt (1990) established that, to improve performance,
organizations need to increase productivity while simultaneously reducing both inventory
and operational expenses. The incoming revenue is the finished goods, the budget
invested in the system is the inventory, and the payments made to make the finished
goods are the operational expenses. The variables of measure in the TOC relate to the
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finance measures of net profit, return on investment, and flow of cash (Goldratt et al.,
1992). Goldratt and Cox (1990) suggested that the following five focus steps are the basis
for the business improvement process proposed in TOC:
1. Identify the constraint(s).
2. Decide how to exploit the constraints(s).
3. Subordinate all else to the decision in the Step 2.
4. Elevate the constraint(s).
5. If in any previous steps a constraint is broken or eliminated, go to Step 1.
Improvement of efficiency in business processes is achievable by using the TOC
based method. Rhee, Cho, and Bae (2010) developed a TOC-based method to enhance
the efficiency of the business process. Rhee et al. (2010) recognized that efficiency is one
of the most important performance measures to achieve. Although Rhee et al. (2010)
applied the TOC-based method to well-structured processes, concluded that TOC
improved processes’ efficiency, especially when the workload is significant and
resources are scarce (Rhee et al., 2010).
Supply chain collaboration amongst independent firms or business units often
provides larger benefits when worked together, as opposed to working in isolation. In
addition, a lack of awareness about the existence of constraints on the supply chain
prevents the benefits of collaboration from being fully realized (Simatupang, Wright, &
Sridharan, 2004). Simatupang et al. (2004) applied the TOC approach to overcome
difficulties in realizing the potential benefits of supply chain collaboration and concluded
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that the TOC approach can be used to expose an inherent dilemma of collaboration and
establish collaborative replenishment policy and collaborative performance metrics to
advance supply chain profitability (Simatupang et al., 2004).
Oglethorpe & Heron (2013) applied the TOC method to identify and overcome
the operational, supply chain barriers, and constraints that occur in local food supply
chains, especially with smaller producers, as they seek to increase market penetration
across a wider geographic area. Oglethorpe & Heron (2013) concluded that the TOC
approach provided an advancement of knowledge in the area of food supply chain
analysis and is conducted in a way that is more practical in use. In addition, Oglethorpe &
Heron (2013) recommended seven broad categories to overcome the operational barriers:
constraints due to the nature of the market, due to scale and the nature of products;
constraints related to employment and skills; institutional constraints; constraints in
supply chain relationships; certification, policy, and regulatory constraints; and
constraints on personal beliefs and anthropomorphism.
The focus of the TOC theory is to maximize the system's performance (Gupta &
Andersen, 2012). Three global measures identified for the TOC theory for evaluating
organizational performance toward the goal of the company are finished goods,
inventory, and operating expenses (Gupta & Andersen, 2012). These three measures are
company-level operational measures of performance and may be used by the company’s
management to achieve continuous improvement (Gupta & Andersen, 2012).
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In addition, Gupta and Andersen (2012) stated that the TOC’s primary assumption
is that at least one constraint in each system limits the ability of achieving higher levels of
performance relative to its goals. Any organization can improve its performance and
move toward achieving its goals by improving the weakest operating activity (Rhee et al.,
2010). When an organization removes the constraint and moves to a higher level of
production or service, a new constraint appears and the cycle of managing the system
with respect to the new constraint resumes (Gupta & Andersen, 2012).
SCM is the basis for a firm’s competitive advantage because it enables the firm to
lower operation costs, increase the service reliability, decrease the inventory level, reduce
order cycle time, lower the number of backorders, improve customer satisfaction, and
improve overall competitive advantage (Ab Talib & Abdul Hamid, 2014). The focus of
this study was to identify and implement best practices in SCM processes that will reduce
operating costs, improve profitability, and facilitate increased availability and
distributions of medicines to patients in desperate need.
The purpose of this section was to provide a review and analysis of the
professional and academic literature relevant to the subject matter. This review will serve
as the basis for a framework for data analyses, which includes the coding and classifies
them into themes. Coding and categorization allow the researcher to classify, sort and
arrange the information in the most efficient, uniform manner (Basurto & Speer, 2012). I
used the Krippendorff (2013), content analysis strategy to generate inferences from large
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bodies of data that reveal trends, patterns, and differences. The literature review will
support the rationale behind the study and the associated interview questions.
Pharmaceutical supply chain. Over the years, the pharmaceutical industry has
evolved to address old and emerging diseases using latest knowledge and technology. As
the industry has been changing in terms of its indispensable role to address diseases, it
has also developed in the dimension of business. In addition, the pharmaceutical
companies has gone through a noticeable structural reorganization (Kelle, Woosley, &
Schneider, 2012). Some of the essential elements of this organization include drug
discovery, delivery mechanisms, launching and marketing, and distribution and
production. Trends show that the periods before the 1990s experienced greater stability in
the industry (Kelle et al., 2012). Various pharmaceutical companies dominated the
industry and had uncontested success for a period of almost a century.
Importance of efficient supply chain distribution. Perhaps the most important
consideration in assessing the impact of the pharmaceutical supply chain processes on an
organization's operational costs is the simulation and the dynamics involved. Gjerdrum,
Papageorgiou, and Shah (2012) developed a standard approach for modeling the
dynamics of supply chain and for testing it on different pharmaceutical processes. The
model incorporates both the physical and business processes. Pharmaceutical physical
processes include manufacturing, distribution and warehousing.
The business processes include decision makers, methods, tools for decision
making, and levels of decision making. The model suggested non-invasive ways of
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improving the operation of the supply chain (Gjerdrum et al., 2012). The proponents of
this model suggested that the improvement of the operation of a supply chain requires
making changes in different parameters and business processes.
The pharmaceutical supply chain brings together many agents with different
objectives (Ripin et al., 2014). The internal dynamics of these agents can work against
organizational performance. For example, if miscommunication among the agents occurs,
a negative impact on the result might ensue. This underscores the role of collaboration of
the agents in forecasting, inventory management, and planning. Agents must coordinate
their activities across the supply chain (Saberi, Nookabadi, & Hejazi, 2012). Larger scale
operations, in terms of geographical spans and different activities, account for the current
practice that is highly distributed (Saberi et al., 2012).
A collaborative planning activity requires the support of scheduling tools and the
multisite planning. The efficiency of a supply chain process depends on the quality of
inventory management and coordination (Haq & Boddu, 2015). The cycle time of the
overall supply chain distribution processes is critical. Reducing the supply chain cycle
time can add to the efficiency of the supply chain that will consequently affect the
organization’s operational costs. In other words, when companies reduce the time span
for a supply chain cycle, making it shorter, the operational costs will be cheaper.
To reduce the total cost of delivering a product to the consumer pharmaceutical
organization’s are going beyond the walls of their organization and working with
suppliers and customers implementing the best SCM practices such as make-to-stock or
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make-to-order strategies. The previous research acknowledged that by following the best
SCM practices in the distribution firms can reduce the costs associated with the
production, transportation, and inventory holding (Ellegood, 2014).
Pharmaceutical organizations have changed from the historical emphasis on
supply chain that only involves manufacturing and distribution of goods to the value
chain supply chain model that manages the innovation and development processes from
capacity to production planning (Wood & Cronley, 2014).
The current focus was to identify innovative ways of exploiting other benefits
from the supply chain. Improvements in strategic-making processes accompany these
changes to allow for responsive supply chains. The ultimate result of such improvements
is an efficient supply chain process that is less capital intensive and, consequently,
reduces an organization’s operational costs.
Difference between Developed and Developing Countries Supply Chain
The pharmaceutical supply chains in developing and developed countries vary in
terms of their organization, financing, function, and ideal characteristics of the bestperforming supply chains (Choi, Narasimhan, & Kim, 2012). Other dimensions of
differences between supply chains are the use of technology and stock levels. Overall,
developed countries have distinct regulatory bodies that regulate the distribution of
pharmaceutical products in the market. Medical practitioners from developed countries
prescribe but third-party players have a role through reimbursement policies (Cameron,
Mantel-Teeuwisse, Leufkens, & Laing, 2012).
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On the other hand, developing countries have limited ability to enforce
regulations and policies on the distribution of pharmaceuticals in the markets, while the
manufacturers do forecast in developed countries with a focus on planning for
production, procurers, guided by demand (Cameron et al., 2012).
The pharmaceutical supply chains in developing countries have low and poor
visibility compared to those in developed countries. In terms of alignment of incentives
and objectives, supply chains in developed countries identify with high-level competition
and routine monitoring (Ellram, Tate, & Feitzinger, 2013). On the other hand, supply
chains in developing countries are difficult to align, and the absence of performance data
hinder the role of incentives. The role and responsibilities of agents involved in the
supply chains of developed countries are systematized because they are well trained
(Zhu, Sarkis, & Lai, 2012).
Supply chain practices in developing countries are weak; roles are unclear, and
there is a high staff turnover compounding difficulties in the supply chains, the
responsibilities for many individuals, and the entities losing focus (Zhu et al., 2012). The
expiration of medicine in the supply chain is a serious threat to the already constrained
access to medicines in developing countries. Privett and Gonsalvez (2014) explained that
medicines used for vertical programs, donated, and manufactured by small revenue
producers are prone to expiry. In addition, they suggested considering lean supply and
stock rotation methods to help in reducing the drug expiry issue.
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So far, this paper has established the gaps that exist in the literature as to the
inadequacy of studies that deal with SCM. In particular, the existing literature lacks
information about organizations’ supply chain effectiveness, reputation for on-time
delivery, and the overall reduction of organizations' operational costs in India.
Indian pharmaceutical industry. In order to understand the topic of medicine
distribution in India, there must be an introduction to the environment of the country
pharmaceutical industry. There are several different factors behind the flourishing of
India’s pharmaceutical industry. Among them, the modification of their laws related to
the intellectual property of a medicine, drug registration, and patent protection to positive
cost/skill ratios.
The regulatory system. The regulatory system of the Government of India has a
federal form that divides the medical regulatory system into national and state authorities.
The principal regulatory bodies that are responsible for the approval, production, and
marketing of quality drugs in India are the following entities (Saranga & Phani, 2009):


Central Drug Standards and Control Organization (CDSCO): This agency sets
standards to ensure the safety and quality of drugs, diagnostics, cosmetics,
devices, and supervision of the importation of drugs.



National Pharmaceutical Pricing Authority (NPPA): This agency fixes or revises
the prices of decontrolled bulk drugs.
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Ministry of Chemicals and Petrochemicals: This organization supervises
pharmaceutical sector policy, planning, development, and regulatory activities
pertaining to the chemicals, petrochemicals.
Figure 1 shows the drug regulatory system of India (Saranga & Phani, 2009). The

national government is at the top. The three ministries that have primary functions in the
drug regulatory system of India are the Ministry of Health and Family Welfare, the
Ministry of Chemicals and Petrochemicals, and the Ministry of Environment and Forests.
The Ministry of Health and Family Welfare and Ministry of Chemicals and
Petrochemicals are the two primary entities of pharmaceutical regulation. The Ministry of
Health and Family Welfare scrutinizes pharmaceutical issues within the larger context of
public health whereas the concentration of the Ministry of Chemicals and Fertilizers
focuses on manufacturing policy.
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Figure 1. Drug Regulatory System of India (Rohit, Nilesh, Ravikiran, Pallavi, &
Pramod, 2012)
Existing regulatory mechanisms. In this section, major regulatory policies in
India are presented. Different laws of manufacturing, selling, importing, and exporting
drugs in India are as follows: The Drugs and Cosmetics Act 1940 (D and C Act); The
Pharmacy Act 1948; The Drugs and Magic Remedies (Objectionable Advertisements)
Act of 1954; The Narcotic Drugs and Psychotropic Substances Act, 1985; The Medicinal
and Toilet Preparations (Excise Duties) Act of 1956, Indian Patent Act of 1970, and The
Drugs (Prices Control) Order of 1995 (under the Essential Commodities Act) (Rohit et
al., 2012). These acts have implications in the SCM in India. For example, the Essential
Commodities Act deals with the availability and affordability of essential medicines or
drugs. This act contributes to this study, as it will shed light on SCM in India, especially
in making medicines available and affordable.
The Drugs (Prices Control) Order of 1995 is an order issued by the Indian
government under the Essential Commodities Act (Rohit et al., 2012). It is an act of price
regulation of drugs. It provides a list of controlled drugs, fixation of drug price
procedures, the fixed method of implementation of prices by the government, and the
penalties for infringement of the Act.
The prices of drugs in India are among the lowest in the world because of several
factors (Berndt & Cockburn, 2014). One of which is the fact that Indian labor costs are
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low compared to other foreign countries (Berndt & Cockburn, 2014). India also has a
large pool of human resource that is competent and is knowledgeable about technical and
managerial tasks (Berndt & Cockburn, 2014). Moreover, most of the equipment needed
to manufacture drugs is available locally. Most importantly, there are many policies in
India about drug price control (Berndt & Cockburn, 2014). Recent policy changes have
an impact on the drug prices in India. The National Pharmaceutical Pricing Authority
(NPPA) heads the price control regime of the country. The government can exempt
certain drugs from price control if these are new drugs discovered in India or if local
small-scale industries produced large bulk of drugs, not by multinational companies.
In February of 2002, there was a proposal to change the “method of detaining
price controlled drugs” and “pricing formula” of drugs in India (Rohit et al., 2012, p. 51).
In 2011, The Department of Pharmaceuticals released a draft note on the National
Pharmaceutical Pricing Policy. Figure 2 shows a simple process of the medicine
distribution mechanism in India (Rohit et al., 2012).
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Figure 2. Regulatory Process of India's Pharmaceutical Industry (Rohit, Nilesh,
Ravikiran, Pallavi, & Pramod, 2012)
Medicine distribution planning. The fast distribution of medical supplies plays a
significant role in ensuring an effective and efficient healthcare system. The medical
supply distribution is about the movement of a large volume of different items that must
be delivered rapidly (Peidro, Mula, Poler, & Lario, 2009). In the United States, most
pharmaceuticals follow this supply chain in order to ensure that the delivery of medical
supplies on time and with high quality (Guido, Mainetti, & Patrono, 2012). In particular,
the medicine supply manufacturers produce numerous medicines as per the demand, and
distributors manage huge warehouses and regulate the movement of medicines from
manufacturers to the retailers. Retailers are comprised of hospitals, clinics, independent
pharmacies, chain pharmacies, and grocery stores.
Differences between Pharma and non-Pharmaceutical Supply Chains
Pharmaceutical supply chains are low on flexibility relative to nonpharmaceutical supply chains. This inflexibility stems from adopting a centralized supply
chain approach for pharmaceutical businesses. A centralized approach to supply chains
overlooks important activities and processes involved in the chain. For example,
pharmaceutical organizations have both, fixed places of production and prices resulting in
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difficulties due to issues of distances to markets and lead times of production and
procurement. Centralization of the supply chain makes it difficult to respond to
competition in certain markets (Wisner, Tan, & Leong, 2015). Most non-pharmaceutical
businesses perceive the SCM as a source of strategic strength that can bring many other
advantages including cost efficiency.
Most pharmaceutical organizations do not use the end-to-end supply chain model
used by most non-pharmaceutical organizations. End-to-end supply chains start with the
organizational structure and reflect the markets in which these organizations operate.
Procurement is among the very first stages of end-to-end supply chains. Interactions with
the vendor and final delivery of goods top patients each have unique steps and that are
interdependent. The lack of sufficient emphasis on end-to-end supply chains is what
accounts for the slow growth of the pharmaceutical business. This translates into
interrupted supply of products to patients that further translates to poor patient
satisfaction (Marshall, 2014).
Many researchers have explored ways to improve the pharmaceutical supply
chain. Susarla and Karimi (2012) developed a simple yet powerful mixed integer linear
programming (MILP) model for multi-period, enterprise-wide planning. The entire
enterprise was represented in a seamless fashion with a granularity of individual task
campaigns on each production line. The model incorporates procurement, production,
and distribution along with the effects of international tax differentials, inventory holding
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costs, material shelf-lives, waste treatment / disposal, and other real-life factors on the
after-tax profit of the company.
Guido, Mainetti, and Patrono (2012) evaluated the impact of radio frequency
identification (RFID) technology, EPCglobal, and ebXML on some business processes
that are crucial to the effectiveness and success of the pharmaceutical supply chain. The
authors focused on the wholesaler because it is representative of the stress point
regarding time and space constraints and product flow. A quantitative and qualitative
analysis of a pharmaceutical supply chain was conducted and concluded that the use of
RFID, EPCglobal, and ebXML was beneficial to the success of the pharmaceutical
supply chain. Staudacher and Bush (2014) examined the way the Lean approach can
impact the pharmaceutical supply chain and confirmed that a drug supply chain can
benefit from the Lean Approach.
Alsmadi, Almani, and Khan (2014) implemented an integrated activity-based
costing (ABC) and TOC approach to enhance decision-making processes of a Lean
company. The results revealed that the integration of ABC and TOC provides managers
with an accurate, timely, and reliable tool that can help in making decisions about
pricing, production line development, process improvements, and product-mix. Sadat,
Carter, and Golden (2013) also found that TOC improves system performance through
leveraging the constraints.
Nagurney, Li, and Nagurney (2013) presented a pharmaceutical supply chain
network model with outsourcing under price and quality competition, in both equilibrium
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and dynamic versions. In the study, the authors considered a pharmaceutical company
that is engaged in identifying the optimal flows associated with its supply chain network
activities in the form of manufacturing and distribution. Moreover, the company seeks to
lessen its total costs and considers the role of contractors in the supply chain. The model
provides information on optimal pharmaceutical product flows, make-or-buy decisions,
and contractor selections. Narayana, Pati, and Vrat (2014) conducted a critical review of
the managerial research on the pharmaceutical supply chain. The authors collated recent
pharmaceutical supply chain literature, published in peer-reviewed academic journals and
found that the research efforts continue to be traditional, as the focus is on efficiency
improvement.
However, there is an emerging interest in process analysis and technology
implementation in the pharmaceutical supply chain. Moreover, the research on the
pharmaceutical supply chain is highly context-specific and focused on developed
economies. The design of the distribution system that most considerably affects the rapid
distribution of pharmaceuticals directly influence the quality of healthcare provided to the
citizens (Mansouri, Gallear, & Askariazad, 2012). The scheme of an effective distribution
system includes the careful thought of two strategic planning concerns, which are the
place used for the facilities, including warehouses and inventories, in support of the rapid
distribution of the medical supplies; and the best strategy that can be used to find the best
routes to distribute the medical supplies.
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Effective pharmaceutical distribution. According to Susarla and Karimi (2012),
a well-managed and well-designed distribution system will have the following features:
(a) sustain a constant supply of medicines, (b) maintain medicines in good condition
throughout the process, (c) minimize loss due to expiration and damage, (d) maintain
correct inventory records, (e) utilize available transportation resources efficiently, (f)
provide information to determine forecasting medicine needs, (g) and integrate a quality
assurance program. The distribution process begins when the manufacturer ships the
medicine and ends when the medicine consumption report is back to the procurement
entity (Susarla & Karimi, 2012).
Inventory management influence on medicine availability. In this section, the
inventory management influence on quantities of finished goods, location of inventory,
and control of incoming and outgoing medicine availability is presented. Kelle, Woosely,
and Schneider (2012) examined the often conflicting goals in decision making amongst
the various stakeholders in pharmaceutical supply chain and explored the managerial
tradeoffs present at the operational, tactical, and strategic levels of decision making. The
authors recommended the use of a tactical decision support that concentrates on relevant
tradeoffs among three major performance indicators: the expected number of daily refills,
the service level, and the storage space utilization. The authors also evaluated the
tradeoffs among the refill workload, emergency workload, and formulary. The results
indicated that the tactical decision support is a tax that improves the current inventory
management of medicines.
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Uthayakumar and Priyan (2013) stated that medicine shortages and improper use
of pharmaceuticals lead to having a significant negative impact on the patients and to
suffering financial losses. As such, they presented an inventory model that incorporates
continuous review with production and distribution for a supply chain involving a
pharmaceutical company and a hospital supply chain. There are several variables
considered in the model such as medicines, variable lead time, permissible payment
delays, limits on space availability, and the customer service level. The model they
presented developed a procedure through which the user could determine optimal
solutions for the inventory lot, size, lead time, and a number of deliveries with minimal
cost to the supply chain. Masoumi, Yu, and Nagurney (2012) constructed a generalized
network oligopoly model with arc multipliers for pharmaceutical supply chain products
using variational inequality theory. The model also encapsulated the economic
competition among the manufacturers who seek to determine the maximization of their
product, which can also be perishable. The model also takes into consideration the
consumers with different product needs and the firms regarding the cost of their products.
The authors also found that a pharmaceutical company might lose its dominant market
share because of patent rights expiration and generic competition. As such, it must
improve its inventory management and logistical management.
Interruptions in procurement. The majority of the drug manufacturers employ
make-to-order production process design. That means these manufacturers would not
start production until they receive final orders for the medical supplies. Some drug
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manufacturers procure the active pharmaceutical ingredient (API) after receiving a
purchase order. In the market, there are only a few sources that could supply API for
most of the drugs. In this case, there is a delay in the procurement of these drugs because
the delivery of the medicine to the country would take several weeks.
Drug manufacturers’ state that poor forecasts, as well as small markets, are the
reasons for the long lead-time required (Ramanathan, 2012). If the forecasts for the
market were uncertain, the drug manufacturer would not keep stocks at hand. If the
national programs could provide advance information about the demand for the
medicines, there would be reduced lead times. This way, sharing order information would
create transparency and increase the efficiency of the process. If there are efficient
forecasting methods, the manufacturers could hold a larger inventory of the medicine
supplies needed. Inventories should be kept strategically in order to resolve the short- and
long-term demand for medicine supplies.
Moreover, procurement delays can arise due to the archaic procurement processes
as well as the lack of a sufficient number of suppliers (Panda & Sahu, 2015). An example
would be the rules and regulations that often impose purchasers to provide further
justification for a competitive market that does not exist.
Distribution setup. The distribution setup is often thin. The logistics of the
government’s management information system are also weak and not systematic.
Government and programs do not know the difference between forecasts and targets. The
concept of forecasting involves specifying the coverage targets and then determining the
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amount of drugs needed in a specific area. However, determining targets and forecasting
of drugs involve comprehensive research. Forecasting methods unsupported by empirical
data will fail (Ramanathan & Gunasekaran, 2014). In order to collect data required for the
forecasting methods, proper coordination among all the stakeholders involved in the
process must take place. Data gathering for medicine purposes must be wisely
coordinated to ensure that the forecasting is accurate.
Demand forecast methods. Forecasting is defined as the process of estimating
the amount of the selected products the program will need to reach the population to be
served (Acar & Gardner, 2012). Forecasts are made to reduce the uncertainty in the
planning and distribution process of the supply chain (Fildes, Goodwin, Lawrence, &
Nikolopoulos, 2009). Demand forecast methods assist in planning the purchasing and
financing aspect of the supply chain. A good forecast model should have the following
characteristics (a) realistic expectations, (b) absorptive capability of the service delivery,
(c) laboratory and supply, (d) good management systems, (e) historical consumption data,
and (f) real-time inventory system all through the supply chain (Acar & Gardner, 2012).
Demand forecasters can draw their forecast from different information and data.
There are usually 17 categories of forecasting methods, out of which 12 categories rely
on the forecasters’ judgment based on own analysis, surveys, and determining intentions
of the market (Stock & Watson, 2012). The remaining five categories depend on
quantitative data (Stock & Watson, 2012). In order to improve forecasting methods, the
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demand forecasters must match the forecast methods that they will use to the problem
and existing conditions.
Forecasting methods. Forecasting methods are different for various products and
contexts (Stock & Watson, 2012). In every program, the forecast is only as good as the
basis of the forecast, which is the relevant information about the supply chain from the
consumers to the manufacturers. The three methods that are recognized for determining
the amount of medical supplies needed in order for a healthcare supply chain to be
successful are discussed next.
Morbidity-Based forecasting. This forecasting method is for new healthcare
programs where there is no consumption data or trend, which will serve as the basis of
the forecast (Vivas-Consuelo et al., 2014). In this sense, the demand for the medicine is
based on the standard guidelines of using the medicine.
Adjusted consumption-based forecasting. In many situations, combinations of
the two methods would be the best option. The adjusted consumption-based forecasting is
used when there is no reliable consumption, logistics, or morbidity data (Vivas-Consuelo
et al., 2014). In this sense, the demand forecasters try to predict the expected need for the
target region without any basis.
In India, the two best methods in 2015 would be Morbidity-Based forecasting and
Adjusted Consumption-Based Forecasting because there is still no institutionalized
structure that gathers reliable data from relevant people involved in the supply chain.
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Forecasting market size. External factors influence the market size in any
industry. For example, the demand for basketball apparel is influenced by the culture,
size, gender, and age distribution of the population (Bazzani & Canavari, 2013). When it
comes to fluctuating markets, forecasts are usually based on judgment. The Delphi
technique is the best example of forecasting market size in fluctuating markets (Abraham
& Ledolter, 2009). When there is sufficient and reliable information available, then the
market is said to be established. As such, the demand forecaster can use different
forecasting methods in order to determine market size such as time-series extrapolation
methods, rule-based forecasting, and causal methods.
Improving forecast methods. Even though the chosen forecast models are
evidence-based, and are appropriate to the problem and context of the situation, there are
still ways to increase the accuracy of the forecast by combining and adjusting forecasts
(Akhlaghi et al., 2011).
First, a forecaster must take into consideration how accuracy will be measured to
determine whether forecasts have improved. Several error measures can be used to assess
forecast accuracy. When it comes to evidence-based forecasting, most analysts
recommend not to use the mean square error (MSE) because it is unreliable (McCarthy,
Davis, Golicic, & Mentzer, 2006). The median absolute percentage error is the measure
that most experts recommend because external factors do not affect it (Akhlaghi et al.,
2011). Another recommendation is the cumulative relative absolute error (CumRAE)
because it is easy to process and interpret (Akhlaghi et al., 2011).
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Combining forecasts. One of the most powerful procedures in forecasting is to
combine forecasts. It is useful when there is no reliable data to use as the foundation of
the forecast. It can be useful when it comes to medicine forecasting because the true
value or amount needed might be between two forecasts made. The extent of error when
combining forecasts is relatively low, compared to relying in one forecast only. In fact,
combining forecasts reduces the probability of error by half (Graefe, Armstrong, Jones, &
Cuz, 2014).
Adjusting forecasts. Judgmental forecasts are biased forecasting methods. In
order to come up with a reliable forecast, one must adjust the forecast based on evidence
of bias from a parallel forecasting situation (Graefe et al., 2014). The forecast must be
based on realistic conditions.
In summary to improve demand forecasts, organizations should use at least two
different forecast methods so that there will be checks and balances with the forecast for
medicine, update data regularly (i.e., logistics, consumption, and morbidity), and
implement an automated or computerized system.
Importance of Transportation in Supply Chain
Transportation refers to the movement of products from one location to another,
as the products are rarely produced and consumed in the same location (Tsao & Lu,
2012). Transportation is a significant part of the supply chain because it delivers the
product from the production location to the consumption location. In addition,
transportation represents one of the essential elements of the cost experienced by most
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supply chains. In global supply chains, especially in the pharmaceutical supply chain, the
role of transportation is even more crucial (Tsao & Lu, 2012).
Transportation is also the physical connection of all manufacturing plants
involved in the supply chain (Chan & Zhang, 2011). The locations in a supply chain
network are referred as nodes, and the connections are referred as links. When one group
sells the product to another, transportation provides the delivery of that product. A
disruption in the supply chain has an effect on all stakeholders.
Transportation is a vital function in any of the supply chains in the world. Supply
chains use responsive transportation to reduce the storage cost by centralizing the
inventory. In order to understand the role of transportation in the supply chain, it is
important to consider the perspectives of the parties involved, carriers and shippers. The
carriers make investment decisions regarding transportation equipment in order to
maximize the return on investment of the assets. They decide whether to use trucks,
airplanes or other modes of transportation. On the other hand, shippers use transportation
to minimize the total costs of operation (e.g., transportation, inventory, facility). Shippers
also provide an appropriate level of responsiveness to customers. Supply chain uses a
mixture of various modes of transportation such as air, package, trucks, carriers, rails,
water, and many more modes to be able to move products from one place to another.
Role of transportation in logistic chain. Logistic chain is part of the supply
chain process that plans, implements, and controls the forward and reverse flow of goods,
services, and related information between the point of origin to the consumer to meet
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customer requirements (Bhattacharya, Kumar, Tiwari, & Talluri, 2014). There are five
important terms in logistics: logistics, materials management, inbound logistics, physical
distribution, and SCM (Bhattacharya et al., 2014). Logistics is the process of movement
of materials and products in and out of the supply chain.
Materials management is about the movement of materials and components
within a firm. Inbound logistics refers to the movement of materials received from the
suppliers. Physical distribution covers the movement of goods outside the firm, from the
production location to the consumption area. SCM has a larger scope than logistics.
SCM oversights the process of moving and handling products from beginning of the
production to the end customers with the goal in mind to satisfy customer needs and
business competitiveness.
Logistics is the process of anticipating customer needs and wants. It is about the
customer-oriented operation aspect of the SCM. Logistics must be managed well, as it
covers the planning and managing of product movements with the goal of minimizing
expenses while maximizing quality service to the customers (Tahvanainen & Anttila,
2011). Transportation has a crucial role that connects several networks in a supply chain
that results in the conversion of resources into useful products for the consumer
(Buyukkaramikli, Gurler, & Alp, 2014). The network consists of production /
manufacturing plants, warehousing services, and retailers. In the manufacturing phase,
the assembly of materials, components, supplies, inventory, and storage functions are
managed within the factory.
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A warehouse service is a logistics management center allowing quick movement
of products by available transportation options. The manufacturers are involved in the
production of goods and leave the rest to marketing and distribution entities to other
teams involved in the supply chain. Warehousing and storage should also be considered
in the production process or production distribution. The majority of the organizations
use consolidation facilities and distribution centers than a single-user warehouse (Askin,
Baffo, & Xia, 2014). This type of consolidated warehouse use offers better
transportations services and improvement of logistics performance (Hofmann & Lampe,
2013).
Transportation costs in SCM. In the 1990s, there were many transportation
services available, which were low-cost services compared to the cost of holding
inventory and storing products in warehouses (Christopher & Holweg, 2011). In this
period, there was a need for fast and frequent delivery to customers through various
means, such as the just-in-time delivery. However, things have changed, as more
companies are looking for long-term strategies in terms of their transportation costs in the
supply chain (Prajogo & Olhager, 2012). The reason for this change is because of
increased oil prices and the imbalance between supply and demand amongst
transportation services, specifically the freight transportation services (Prajogo &
Olhager, 2012). These instances have lead to high transportation costs and forced
organizations to make necessary changes in their supply chain strategies to control
concerns.
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There are three shifts that have affected the transportation supply chain strategies
of business firms today. The first shift was the change from offshoring to nearshoring
(Ellram et al., 2013). Organizations decided it was cheaper to look for resources that are
available near them and look for near locations to produce and sell the products that
would minimize the transportation travel time.
The second shift was on the product design change from consumer attraction
package to a more efficient design considering transportation challenges in mind (Khan,
Christopher, & Creazza, 2012). These designs often consider the space efficiency in
terms of size, shape, and protection of the products. The third shift was from having a
lean inventory management to a hybrid of lean inventory and transportation management
(Nag, Han, & Yao, 2014).
Companies having adopted these shifts in strategy indicate that the benefits of the
change go beyond minimizing the challenges of transportation. These shifts have also
improved both the supply chain and the financial performance because of lower costs and
more investments that are productive.
Shift 1: Offshore to Nearshore sourcing strategies. Many firms are shifting
their supply strategy from offshoring to the nearshore. This change is happening because
of high oil prices with the goal of reducing the international transportation cost and the
products’ travel time. In addition, the shift to nearshoring offers additional benefits, such
as reducing the disruptions at the shipping ports and avoiding the cross-country
movement of products. The shortened distance and reduced risk of congestion would
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mean that there would be fewer delays to the transportation aspect of the supply chain
(Hajibabai & Ouyang, 2013). In general, this shift is both beneficial to the customer and
to the supply chain. It would also lessen the transportation costs, which would reduce the
cost of the product.
Nearshoring strategies also attempt to reduce the length of the transportation
pipeline that would impact the freight costs, revenue, and inventory. The freight costs are
reduced because there is a reduction in the miles traveled. Revenue is improved because
this strategy offers shorter product travel distances, responding more efficiently to the
needs of the market. Finally, the on-hand inventory is reduced because replenishment
takes less time, as product availability is near (Hajibabai & Ouyand, 2013).
Shift 2: Product designs that emphasize shippability. The majority of the
companies are redesigning their products to attract customers with the transportation
issue in mind (Serdarasan, 2013). For instance, some products have a new formula, such
as laundry detergent, dairy powder, and fruit juice to make them more concentrated. As
such, the consumer only has to buy the product in small quantities with the same quality.
In the area of consumer products, such as the toilet paper, transportation uses the smaller
size cardboard tubes to reduce space when it is transported to other locations (Serdarasan,
2013). As a result, more toilet paper is transported at the same transportation costs. Some
manufacturers have even eliminated the need for the cardboard tube in the middle.
Packaging also has been redesigned to optimize the package size and weights
(Bourlakis, Maglaras, Gallear, & Fotopoulos, 2014). Most manufacturing companies use
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lighter weight materials and remove the redundant packaging layers such as outer
cartons. Products are lighter and come in small package sizes. These light and small
package sizes also help lessen the transportation costs of the products (Closs, Speier, &
Meacham, 2011).
For instance, pasta sauces and condiments can be purchased with flexible
pouches, as opposed to the typical jars (Closs et al., 2011). This strategy has an impact on
the supply chain. Before redesign of the package, most manufacturers are careful in the
area of transportation. As such, this strategy helps to reduce the shipping weight and size
of the product while maintaining the quality to attract the consumers. In addition, the
revenue increases by means of better utilization of valuable shelf space. These changes
would translate to cost savings in freight and packaging expenses, as well as space
utilization.
Shift 3: Lean inventory strategies. The lean theory and practice has the aim of
reducing inventory costs that would enable the firms to have more revenue (Li & Chen,
2013). Lean strategies adopted by companies include just-in-time delivery, small, fast,
and frequent delivery methods using a dedicated fleet of transportation vehicles.
However, with rising oil prices, these strategies were no longer an option for companies
if they choose to have more revenue. Moreover, companies have to think of a balance
between the inventory and transportation. As a result, companies have implemented a
hybrid of the inventory and transportation strategies that would focus on the storage of
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products and the reduction of transportation costs. Some shippers have turned to
shipment consolidation.
These firms examine their shipment patterns in order to find ways to consolidate
their shipments, as well as, considering a third-party logistics provider in order to ship
products within the shared routes. Shippers are also considering the capacity utilization.
The firms examine their capacity to ensure that capacity would be optimized for each
shipment. Shippers are also looking at lower-priced alternative modes of transportation,
such as relying on rail services rather than using truck services for long-distance
shipment.
In the supply chain, these shifts reflect lower transportation costs that would
offset the increased inventory costs of the firm. When a firm ships larger loads, higher
levels of inventory on hand are secured. Some shippers would consider using the longer
transit options such as the intermodal rail in order to replace the higher costs of using
freight trucks. Moreover, the increase in inventory costs is offset by the reduction of costs
through improved shipment frequency, shipment capacity, and vehicle utilization
(Barney, 2012).
A firm’s revenue increases because inventory is more available to fill the
demands of the market with a shorter lead-time. The fact that transportation costs would
replace the inventory costs does not mean that the inventory aspect would become less
significant in the logistic supply chain. Quite the opposite, these hybrid inventory and
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transportation strategies would highlight the balance between inventory and
transportation costs (Barney, 2012).
Impact of transportation disruptions on supply chain performance.
Transportation disruptions are caused by various issues, such as natural disasters
earthquakes, terrorist attacks, congestion at ports, sanitary controls, time-consuming
customs inspections, glitches in customs software, and lack of capacity in the
transportation network to accommodate the demand or labor disputes among its
employees (Qiang & Nagurney, 2012).
Transportation disruptions increase the lead time variability from the production
to availability of the product to the consumers (Bueno-Solano & Cedillo-Campos, 2014).
As such, companies needed to require greater levels of inventory safety stock. If the
inventory safety stock is unchanged, the supply chain performance of on-time delivery
and stock-out rates would ultimately decrease. Clients would not receive their products
on time, and the costs would also increase because the demand of the product is higher
than the supply. In a larger level, the delay or disruptions in large-scale freight also have
a crucial impact on the economy of the country.
The backbone of the modern society is the supply chain transportation network.
The reliability of this network has a vital role in the market. Any threat to the supply
chain transportation network would be considered a weakness for the supply chain itself.
In addition, unreliable transportation network would cause extra costs for the supply
chain. It would also lead to a reduction in the efficiency of the system.
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Transportation disruptions lead to the delay or even stoppage of the flow of
products in the supply chain. For example, the terrorist attack on the World Trade Center
resulted in a stoppage of assembly lines of Ford because of the delay of products in the
Canadian and Mexican border (Cedillo-Campos, Sanchez-Ramirez, Vadali, Villa, &
Menezes, 2014). Customs were very strict about inspecting each of the shipment that
caused congestion at the airports and ports.
Impact of Supply Chain Best Practices
An organization's competitive advantage creates a defensible position in the
market over its competitors (Barney, 2012). It includes the ability of the firm to be able to
differentiate itself from its competitors in the market. The empirical literature on
competitive advantage reveals that “identifying price/cost, quality, delivery, and
flexibility as important competitive capabilities” (Barney, 2012, p. 4). In addition,
researchers have stated that time-based competition is a priority for an organization if it
wants to develop or maintain its competitive advantage.
A framework for competitive advantage includes the following: “competitive
pricing, premium pricing, quality, dependable delivery, and production innovation”
(Barney, 2012, p. 4). As such, the dimensions of competitive advantage include the price
of the product, the quality of the product, the delivery dependability of the product, and
the innovative capability of the product.
Organizational performance is about whether the organization has achieved its
market-oriented goals, as well as the financial goals (Deshpande, 2012). The short-term
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objectives of SCM refer to the increased productivity of the production phase and to
reduce the inventory cycle time. The long-term objectives of SCM are to increase the
market share of the organization, as well as an increase in the profit for all members of
the supply chain. Any organizational initiative that includes the SCM should lead to an
increase in organizational performance.
Based on a review of literature published to date, it appears that lack of best SCM
strategies, knowledge, and skills in the healthcare industry has an impact on organizations
SCM cost associated with the production, transportation, procuring, forecasting and
inventory holding (Ellegood, 2014). Leaders of healthcare business organizations are
interested in identifying and implementing best practices in SCM processes, to reduce the
operating costs, improve profitability, and facilitate increased availability and
distributions of medicines to patients in desperate need.
A review of the literature indicated that, to date, more researchers conduct
quantitative than qualitative analyses. The qualitative nature of this study may contribute
to a fresh, in-depth, holistic perspective to the SCM strategies that Indian business leaders
could use in the healthcare industry to reduce the high costs associated with SCM.
Transition
In Section 1, I presented the background of the problem; problem statement;
purpose statement; nature of the study; research question; interview questions; conceptual
framework; definition of terms; assumptions, limitations, and delimitations; significance
of the study; and review of the professional and academic literature. Previous authors
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have focused much of their research surveying and interviewing top management and
supply chain experts to gain an understanding of the SCM strategies that Indian business
leaders have used in the healthcare industry to reduce the high costs associated with SCM
(Ellegood, 2014; Gjerdrum et al., 2012; Haq & Boddu, 2015; Saberi et al., 2012). Several
researchers provided information to improve the SCM strategies and results of an
organization implementing improvement processes.
In Section 2, I will reinstate the purpose statement and presented the role of the
researcher, study participants, research method and design, population and sampling,
ethical research, data collection, data analysis, and reliability and validity of the study. In
Section 3, I will reintroduce the purpose statement, provide a brief summary of the
findings in the introduction, discuss in detail the application of the study to professional
practice, present the implications for social change, and conclude the section with my
recommendations for action and further research.
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Section 2: The Project
This section outlines the methodology and data collection process used in
exploring the supply chain distribution practices and processes of medicine companies in
India. In addition, this section presents: (a) the restatement of the purpose, (b)
methodology, (c) the role of the researcher, (d) study participants, (e) justification of the
research method and design, (f) population demographics and sampling utilization, (g)
data collection, (h) data analysis techniques, (i) reliability, and (j) validation factors.
Purpose Statement
The purpose of this qualitative study was to explore the SCM strategies that
Indian business leaders have used in the healthcare industry to reduce the high costs
associated with SCM. I used a case study research design approach to explore the SCMrelated problems in the distribution of pharmaceutical drugs in India.The sample
population consisted of three business leaders working in India healthcare organizations
that are successful in using SCM strategies to reduce the high costs associated with SCM.
These individuals are the key stakeholders who have the responsibilities to manage the
SCM strategies. The research design included the following data sources: (a)
semistructured interviews, (b) company documentation, and (c) observations. The social
impact of this study was that its results may enable leaders of healthcare business
organizations to identify and implement best practices in SCM processes in order to
reduce operating costs, improve profitability, and facilitate increased availability and
distributions of medicines to patients.
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Role of the Researcher
The researcher is responsible for developing and executing a study report (Yin,
2014). Critical researcher responsibilities include: (a) creating and asking relevant
questions, (b) interpreting responses from research studies, (c) maintaining flexibility to
unforeseen happenings, and (d) maintaining an understanding of the research problem
(Yin, 2014).
The accuracy of a qualitative study depends on the experience of the researcher
and his or her ability to draw conclusions from the data based on the results (Bernard,
2013). I am an experienced business and information technology professional with over
18 years of experience in pharmaceutical industry. I hold a Master of Science (MS)
degree in computer science and am a certified project manager with overseeing
responsibilities of pharmaceutical clinical supplies distribution. I applied my skills and
experience as part of this research study.
In conducting this qualitative case study, I performed all tasks associated with
data collection and analysis of the study. In qualitative research, the researcher is the key
instrument and described that researchers must remain unbiased (Marshall & Rossman,
2011). Researcher bias can change the direction or result of the case study (Yin, 2014). I
was unbiased, impartial, and nonjudgmental throughout the research process.
The tasks included recruiting a minimum of three business leaders working in
healthcare organizations in India who were open to sharing their insights on SCM
strategies that could be used by other business leaders to reduce the high costs associated
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SCM. In addition, I asked permission of participants to audio-record the interview session
to ensure the accuracy of transcriptions. I developed the semistructured interview
questions and conducted individual interviews via Skype with each of the participants
who agreed to be part of the study.
The interview protocol is important because some participants may decide not to
participate in a study based on interview protocol alone especially if the study focused on
a sensitive topic (Leedy & Ormrod, 2013; Knox & Burkard, 2009). Also, different
researchers could run parallel studies each using different levels of interview protocol
structures. The findings of these studies with respect to the richness of the data and
similarities of results may reveal useful information about strengths and weaknesses of
different interview protocol designs (Knox & Burkard, 2009).
Researchers should follow a basic code of conduct while undertaking case study
(Yin, 2014). The Belmont Report (National Commission for the Protection of Human
Subjects of Biomedical and Behavioral Research, 1979) provides ethical guidelines for
the following three principles: (a) beneficence, which means that the researcher must
increase benefits while minimizing risk; (b) respect for persons voluntary involved in
research; and (c) justice, fair distribution of benefits and risks for potential research
subjects (Cugini, 2015). Similar to Cugini (2015), as a researcher, I followed the ethical
guidelines, as outlined by the Belmont Report, and the strict confidentiality of their
participants concerning the handling of the responses and their anonymity in all
documentation of the study.
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Participants
The quality and validity of a research study consist of the study’s: (a) population,
(b) contact method, (c) participation rate, and (d) refusal rate (Cox, 2012; Morton,
Bandara, Robinson, & Carr, 2012; Tufford & Newman, 2012). The population in this
study included business leaders having the accountability to manage the medicine supply
chain and distribution in India. The participants are part of a pharmaceutical organization
and members of the SCM group with supervisor responsibilities to manage the medicine
supply chain and have been in their role for at least two years. These business leaders rely
on SCM employees and distribution professionals to manage the medicine distribution to
retailers and end users. Thus, distribution professionals are knowledgeable in the day-today operations, practices, processes, and challenges of distributing medicines.
Moustakas (1994) suggested that in qualitative research, experiences of the
phenomenon serve as the basis for selection of study participants. Guest, Bunce, and
Johnson (2006) suggested that guidelines for determining nonprobabilistic sample sizes
are virtually nonexistent. Miles, Huberman, and Saldana (2013) concluded that a smaller
sample size, as opposed to a larger sample size is sufficient in qualitative research. The
population frame for this research study consisted of leaders of SMEs included in my
professional and social network. For the last 15 years, I have been working in the
pharmaceutical industry, specifically Pfizer, and have established good connections with
leaders of other organizations. I leveraged these relationships to recruit the right
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participants to this study. In addition, by explaining the purpose of the study and its
potential benefits to society I built the trust in working relationship with participants.
Upholding ethical principles throughout the research process is critical (Fiske &
Hauser, 2014; Gibson, Benson, & Brand, 2013; Oquendo, Stanley, Ellis, & Mann, 2014).
To protected participants’ rights, I used the coded data and stored all electronic
information on a password-protected laptop.
Research Method and Design
The research method and design provide the framework that bound the research
project. Qualitative studies focus mainly on providing an in-depth understanding of the
central phenomenon while quantitative studies are focused on describing trends and
explaining relationships between variables (Bhattacharya et al., 2014; Cox, 2012; Tufford
& Newman, 2012). I employed qualitative methodology because it supports a deep, openended exploration of distribution practices and challenges in a bounded system, which is
the distribution network of medicines in India. This research method is consistent with
the purpose of the study, which focused on understanding a phenomenon rather than
measuring constructs. Therefore, I employed a qualitative methodology to explore the
SCM strategies that Indian business leaders have used in the healthcare industry to reduce
the high costs associated with SCM.
Research Method
A quantitative study would not provide the depth of insight or details that are
required to investigate the issue and is limited by narrowly defined variables (Corbin,
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2014; Ella, Kangarloo, & Daly, 2013; Golicic & Davis, 2012). Therefore, quantity
research methodology was not selected. Mixed-methods research methodology is a
combination of both qualitative and quantitative methods, typically using a pragmatic
worldview, which includes multiple data types to understand the problem (Ella et al.,
2013; Golicic & Davis, 2012; Yin, 2014).
The purpose of this study was not to support the results based on preconceived
hypothesis, but rather to explore the SCM strategies that Indian business leaders have
used in the healthcare industry to reduce the high costs associated with SCM. A mixed
method approach might have provided a further intense view into the research topic;
however, the mixed method research approach was not most viable research option for
this study given the additional complexity. For this reason, I did not selected the mixed
method research method.
I selected the qualitative research method for my study. The qualitative research
method incorporates open-ended questions that represent the basis for an in-depth
exploration of the phenomenon (Corbin, 2014; Hays & Singh, 2012; Marshall &
Rossman, 2011). A qualitative approach provides a rich description of the activity taking
place (Corbin, 2014; Hays & Singh, 2012; Marshall & Rossman, 2011). The qualitative
method is appropriate for studies that explore the specific phenomenon in a real setting
that is not readily available using the quantitative method (Corbin, 2014; Cox, 2012;
Tufford & Newman, 2012). Therefore, I determined that the qualitative research method
was the most appropriate for this inquiry over other research methods.
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Research Design
The purpose of this qualitative study was to explore the SCM strategies that
Indian business leaders have used in the healthcare industry to reduce the high costs
associated with SCM. The five major types of qualitative research design approaches
include ethnography, grounded theory, phenomenology, content analysis, and case study
(Hays & Singh, 2012; Nakai, 2012; Yin, 2014). The case study research design approach
was deemed most appropriate for this study because I asked participants to answer openended questions regarding current practices, experiences, disruptions, and challenges
faced in distributing medicines in India. The use of a qualitative approach allowed me to
collect data that are specific to a particular context to understand an issue, as
recommended by several scholars (Hays & Singh, 2012; Nakai, 2012; Yin, 2014). In this
case, that issue is the distribution practices, processes, disruptions, and challenges for
medicines in India.
I determined that a case study research design approach was the best suited for
this study. I considered other qualitative research design approaches but deemed
inappropriate because they are not best suited for the purpose of my study and the
available resources. For instance, the purpose of the grounded theory research design
approach is to generate alternative treatment theories or methods (Corbin, 2014; Ella et
al., 2013; Mena, Humphries, & Choi, 2013). For this reason, it was not suitable for this
study. Action research requires unrestricted access to the participants (Berg, 2004;
Corbin, 2014; Yin, 2014) and, consequently it was not suitable for my study.
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I did not use a phenomenological research design approach because it focuses on
the exploration of perceptions of the participants in a particular phenomenon based on
their lived experiences. A phenomenological study on this topic would focus on the lived
experiences and the participants’ personal interpretation of the lived experiences in terms
of distributing medicines. Thus, this could provide subjective interpretations, which could
provide bias interpretations on practices and challenges encountered in distribution
facilities (Bourlakis et al., 2014; Corbin, 2014; Silvestro & Lustrato, 2014).
According to Yin (2014), the goal of case studies is to understand complex social
phenomena, such as organizational and managerial processes. This particular study
focused on the process used to distribute medicines down the supply chain in distribution
facilities. In the data collection process, the interviews represent one of the most
important aspects of a qualitative case study (Hays & Singh, 2012; Corbin, 2014; Yin,
2014). The concept of data saturation, originally developed for grounded theory studies
but applicable to all qualitative research that employs interviews as the primary data
source, entails bringing new participants continually into the study until the data set is
complete, as indicated by data replication or redundancy (Cox, 2012; Marshall, Cardon,
Poddar, & Fontenot, 2013; Tufford & Newman, 2012). I conducted individual interviews
by Skype with each of the participants until the data set was complete and the required
quality was achieved.
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Population and Sampling
The purpose of this qualitative study was to explore the SCM strategies that
Indian business leaders have used in the healthcare industry to reduce the high costs
associated with SCM. The target population for this study was business leaders,
distribution managers, and professionals working in medicine distribution facilities in
India. I identified the participants based on their expertise of medicine distribution to
ensure that their answers would help me respond to the overarching research question
posed in this study. I selected purposefully sampling inclusive of professionals who had
the same function for at least two years.
Multiple types of sampling strategies and techniques are available to achieve the
goals of qualitative research. Acharya, Prakash, Saxena, and Nigam (2013) posited
purposive sampling for case study design as less expensive than random sampling and
more conducive to the study. Consequently, I used a purposive sampling technique to
gather participants for the study. A purposive sampling technique is a nonprobability
sampling technique where the gathering of participants focuses mainly on individuals
who could provide valuable insights regarding the phenomenon considered in the study
(Bhattacharya et al., 2014; Evans & Buehner, 2011; Gligor, Holcomb, & Stank, 2013).
Purposive sampling requires researchers to select deliberate participants with an
explicit purpose in mind, specifically to address the purpose of the research. This
technique is typically designed to pick a small number of cases or participants that will
yield more information about a particular phenomenon (Corbin, 2014; Evans & Buehner,
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2011; Yin, 2014). According to Corbin (2014), there is no sample set size necessary for
qualitative studies. However, it is critical to ensure that the sample size is not too small
to achieve data saturation or too large that it is difficult to conduct data analysis. To
achieve the data saturation, I conducted three interviews with each individual participant.
The first interview was to capture in-depth data, with the second interview served as a
follow-up while the third interview provided an opportunity for member checking.
Marshall and Rossman (2011) stated that additional interviews may be required until the
researcher achieves data saturation. I followed up with the participants to seek additional
information or clarification on previously answered responses to ensure data saturation.
Ritchie, Lewis, Nicholls, and Ormston (2013) stated that it is impossible to do
justice to the richness of the data yielded if the sample is large scale. However, small
sample size only works if good purposive sampling has taken place (Evans & Buehner,
2011; Gligor et al., 2013; Ritchie et al., 2013). The participants received an assurance that
their privacy and confidentiality will be maintained all times. All data collected from
participants will remain in a safe place and the data analyzed do not include their names.
I informed the participants and will destroy the collected data 5 years after completion of
this study to comply with Walden University's requirements for a DBA doctoral study.
Ethical Research
The safety and confidentiality of the participants are the most important ethical
aspect of conducting the study. This study is not controversial or sensitive in nature and
did not present any ethical concerns. I followed Walden University’s Institutional Review
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Board's (IRB) guidelines and did not start my study until IRB approval has been granted.
I conducted this study under the Walden University IRB approval number 11-10-150171351. Ritchie et al. (2013) described the role and responsibilities of a researcher
during planning and execution of the study to protect the anonymity of the informants, by
assigning numbers or aliases to individuals. Further, to gain support from participants, I
explained the purpose and benefits of the study to them (Evans & Buehner, 2011; Gligor
et al., 2013; Ritchie et al., 2013).
I answered all prospective participants’ questions and/or concerns pertaining to
this study prior and/or during this study. Participation was voluntary, and no
compensation was given to any participants in this study. Any employee participating in
the study was given the choice not to take part or to withdraw from the study, even after
it had begun. Refusal to participate or withdrawal from the study did not involve penalty
or loss of benefits for either participant or myself. Unanticipated ethical issues did not
arise during the course of the study due to the nature of qualitative research. The primary
ethical issue that will demand attention is that of confidentiality and privacy of the
participants (Corbin, 2014; Gibson et al., 2013; Oquendo et al., 2014).
To circumvent issues of confidentiality, the researcher asked for the anonymity of
the participants signing an informed consent form (see Appendix A) to ensure that they
agree to participate in this study. Moreover, I used fictitious names of people and
institutions. Informed consent ensured that participants entered the study voluntarily and
understood the focus of the study, as recommended by the experts (Gibson et al., 2013;

58
Hays & Singh, 2012; Oquendo et al., 2014). This study did not employ any identifiable
information throughout its duration. Moreover, the researcher kept the data gathered from
this study in a password-protected computer and stored in a locked cabinet. I am the only
person with access to the data and will destroy them five years after the completion of the
study to comply with Walden University's requirements for a DBA doctoral study
(Ekekwe, 2014; Ellegood, 2014; Sapp, 2014).
Data Collection Instruments
One essential skill for data collection is to stay aligned (Corbin, 2014; Moustakas,
1994; Yin, 2014). To stay aligned, a researcher must have a clear interpretation of the
purpose of a study and be able to make an unbiased, analytical judgment throughout the
data collection activities (Corbin, 2014; Moustakas, 1994; Yin, 2014). Upon approval
from Walden University's IRB to conduct the study, potential participants were contacted
(see Appendix B) via email. I scheduled interviews when enough contacts agree to
participate in the study. A qualitative researcher is the main instrument for data collection
(Leedy & Ormrod, 2013; Moustakas, 1994; Yin, 2014). For this reason, I was the primary
data collection instrument for my study.
The interview protocol sometimes referred to as Interview Guide, is the secondary
instrument throughout the interview with all participants (Leedy & Ormrod, 2013;
Merriam, 2014; Moustakas, 1994). I developed an interview protocol (see Appendix C)
to ensure that interview questions yield specific information needed to address the study’s
guiding question and sub-questions. I conducted semistructured interview sessions
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through the Skype to observe participants while responding to the interview questions
and to gather qualitative data for this study. Using the same interview protocol
throughout the study assisted me to ensure the consistency of the semistructured
interviews.
Semistructured interviews involved open-ended questions, which allowed
participants to express and share their perspectives, insights, and knowledge using their
own words. Participants were encouraged to share their experiences and to believe that
their opinions are important, as recommende by several scholars (Drew, 2014; Lincoln &
Guba, 2011; Merriam, 2014). Marshall and Rossman (2011) argued that semistructured
interviews are the most effective means for the researcher to gain a deep understanding of
an individual’s experience and fully address the research question. The use of
semistructured interview questions ensures that the interview questions address the
suggested research inquiry (Drew, 2014; Lincoln & Guba, 2011; Merriam, 2014). The
responses of participants to the interview questions were analyzed using Krippendorff’s
(2013) content analysis.
Member checking was defined as a tool to assure data credibility and validity
(Corbin, 2014; Harper & Cole, 2012; Lincoln & Guba, 2011). Marshall and Rossman
(2011) defined member checking as a process whereby the researcher provides
participants with the opportunity to review the interpretation of their responses in support
of data completeness and interpretation accuracy. I sent the interview transcribed data
back to the participant to ensure the accuracy of the data. When participants were
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provided a transcript to member check for accuracy, a few additional questions were
asked to expand upon original answers to offer additional information.
Further, I used data triangulation to ensure the reliability, confidence, and
accuracy of data. I used different data sources in the triangulation, including (a)
semistructured interviews, (b) company documentation, and (c) observations.
Triangulation is the process of validating data findings using multiple sources of data,
individuals, theories, or different data collection methods (Corbin, 2014; Harper & Cole,
2012; Lincoln & Guba, 2011). The data are indicative of associated themes across
multiple data sources that aided in the assessment, interpretation, and development of
conclusion from the information collected.
Data Collection Technique
When the researcher’s goal is to obtain knowledge on a particular topic with a
prepared number of questions, the researcher should use a semistructured interview
(Marshall & Rossman, 2011; Rubin & Rubin, 2012; Yin, 2014). Researchers use probing
questions to obtain the most relevant, accurate, and in-depth information (Marshall &
Rossman, 2011; Rubin & Rubin, 2012; Yin, 2014). If the study participants did not fully
address the questions inquired or shared an inadequate answer, rephrasing strategies and
probing questions stimulated additional related responses.
The population for this study consisted of three business leaders having the
responsibility to manage medicine supply chain strategies and distribution in India. The
participants are part of a healthcare organization and members of SCM group and have
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been in the role for at least two years. Upon approval from University's IRB to conduct
the study, potential participants were contacted (see Appendix C) via email to confirm
their participation and secure the signed informed consent form (see Appendix A), and
conducted the pilot study before scheduling the interview.
Moustakas (1994) noted that repeatability and consistency in the data collection
technique increase the dependability and relevance of each event (see Appendix C). All
interviews were recorded and each interview took 25 to 30 minutes to conduct. The target
population for this study was business leaders, distribution managers, and professionals
working in medicine distribution facilities in India.
The telephone interview data collection technique has been judged to be rich,
vivid, detailed, and of high quality (Corbin, 2014; Rubin & Rubin, 2012; White,
Castleden, & Gruzd, 2014). Telephone interviews can be an effective method of data
collection when interviewers understand the potential benefits and challenges. The
advantages of a telephone interview include that it (a) can reach wide geographical
locations, (b) can reach the potential participants residing in the restricted site access
locations, (c) has access to dangerous or politically sensitive site participants, (d) can
reach multiple participants in various locations in one day, and (e) has no travel costs
(Hancock & Algozzine, 2011; Rohde, Lewinsohn, & Seeley, 2014; White et al., 2014).
The potential disadvantage of a telephone interview is that the interviewer has no
view of the situation in which the interviewee is situated, and less social and nonverbal
cues are observed (Hancock & Algozzine, 2011; Rohde et al., 2014; White et al., 2014).
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To overcome this challenge, I gathered data from conducting semistructured interviews
through Skype at potential participants’ convenient time and location to ensure that
participants are in a comfortable place. Ensuring the comfort of participants allow ed them
to give their opinions and ideas freely regarding the subject.
Case study researchers often opt to review existing documentation related to the
research questions (Hancock & Algozzine, 2011; Rohde et al., 2014; White et al., 2014).
In addition to conducting the semistructured interviews with business leaders and subject
matter expertise in SCM, participants' company documentation was used as another
source of data collection. Before closing my interview facilitation with each participant, I
requested the participants to share their company SCM processes and procedures
documentation via email. The study population was narrow enough to produce a clear
outcome based on qualitative data obtained through interviews and from inspecting
company documentation.
Upon approval from Walden University's IRB to conduct the study, I conducted a
pilot study. Pilot testing is a critical element of research validity (Merriam, 2014; Sapp,
2014; Yin, 2014). I conducted the pilot study using one business leader and one
employee, not participating in this study, who have been successful in taking advantage
of the best practices and SCM knowledge in India. I contacted them (see Appendix B via
telephone to confirm their participation and secure the signed informed consent forms
(see Appendix A) before scheduling the pilot interview.
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Conducting the pilot study was to assess the research design will produce the
results as intended. In addition, it gave me an opportunity to revise the interview
questions as needed to achieve the study objectives, and resolve the interview protocol
(see Appendix C) execution difficulties. In the event, pilot study results would have
suggested revising interview questions or the interview protocol, I would have reached
the pilot participants again to collect additional data using revised questions.
To overcome this problem, I formulated the interview questions to ensure that
participant responses will provide valuable insights regarding the research questions
planned in this study. The interview questions are based on researching the content of the
study, the literature review, and my experience. To ensure the reliability, I used the expert
validation strategy, which involves presenting the interview questions to experts for their
views (Ekekwe, 2013; Merriam, 2014; Yin, 2014). I reviewed the interview questions
with experts from Pfizer to ensure that the questions are relevant and that the interview
protocol achieves trustworthiness, credibility, dependability, and clarity.
Member checking occurs by allowing participants in the study to review
transcriptions and initial interpretations (Corbin, 2014; Harper & Cole, 2012; Lincoln &
Guba, 2011). Upon completion of the interview, I transcribed the recorded interview and
shared it with study participants requesting their review of their answers to interview
questions to ensure the accuracy of the data. If there is a need to make changes to the
original transcribed data, I documented the changes in a separate log for tractability
purposes.
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I took the time to perform member checking interviews to gain more in-depth
information, accuracy, credibility and to reach the data saturation. As the data unfolded,
patterns of both regularities and irregularities were sought. As themes emerged,
categories were created, allowing information to be sorted. In addition to member
checking, I used data triangulation to ensure the reliability, confidence, and accuracy of
data.
The selection of the appropriate method, design, and instrumentation will ensure
the assembly of accurate data and enabled the formation of accurate conclusions (Frels &
Onwuegbuzie, 2013; Hancock & Algozzine, 2011; Rohde et al., 2014). Data saturation
occurs when no new data add to the findings or themes. Additional interviews may be
required until the researcher achieves data saturation (Guest et al., 2006; Marshall &
Rossman, 2011; Moustakas, 1994). I followed up with the participants to seek additional
information or clarification on previously answered responses to ensure data saturation,
as the focus is to retrieve extensive and influential responses.
Data Organization Technique
Data organization and analysis assist the researcher in answering the overarching
research question (Basurto & Speer, 2012; Cassell & Symon, 2011; Wahyuni, 2012). For
easier retrieval and analysis, I stored all the collected data in an electronic form in a
secure folder on the external hard drive. In addition, I kept track of each (a) signed
consent form, (b) invitation to participate in the study, (c) interview transcripts and
interpretation of each interview data for member checking, (d) audio recordings, (e)
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company documentation, (f) research logs, (g) reflective journals, and (h) labeling system
of paper and electronic forms of data.
I transcribed the audio recorded responses into Microsoft Word and reviewed
them with participants first for their concurrence with their answers, and then use it for
analysis. In the event that a participant’s response does not generate the required evidence
or does not match the degree of correspondence, information from that participant will
not be considered in the analysis (Cassell & Symon, 2011; Wahyuni, 2012; Yap &
Webber, 2015).
To ensure the confidentiality and anonymity of the participants, no identifiable
information was documented in the study. A researcher can achieve confidentiality and
anonymity of each participant by assigning generic codes to each participant (Bell &
Waters, 2014; Gibson et al., 2013; Hancock & Algozzine, 2011). For cataloging, I
indicated the coded sequential representation of the participants’ name (e.g., ‘respondent
1’) on the copy of the consent form and the audio recordings. In addition, I used the
generic naming convention while saving the scanned copies of signed consent (see
Appendix A), participant invitation (see Appendix B), audio recordings, and the
interview transcriptions.
A research log is an ongoing diary of a researcher tracks of the progress of
research (Bell & Waters, 2014; Merriam, 2014; Yin, 2014). I kept track of the research
log with planned and completed literature searches, the purpose of each search and, a
summary of findings with notes. In addition, I documented my research experience in a
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reflective journal with the details of what happened and why and, what can I learn to
improve the process.
Qualitative analysis requires grouping and regrouping raw data into themes and
subthemes and organizing them into classifications constructed on thematic exploration
(Leedy & Ormrod, 2013; Merriam, 2014; Moustakas, 1994). I organized the collected
data into different themes to make the analysis easier. Yin (2014) noted that there is no
way to anticipate which themes will emerge from the collected data when contemplating
a prior coding.
I secured both paper and electronic data in a locked cabinet. I am the only person
who has access to the secured cabinet. I will destroy the files and data five years after the
completion of the study to comply with Walden University's requirements for a DBA
doctoral study (Ekekwe, 2014; Ellegood, 2014; Sapp, 2014).
Data Analysis
Credibility concerns the confidence in the result. Triangulation involves using
more than one data source to study a phenomenon and has been found to be beneficial in
providing confirmation of findings, more comprehensive data, increased validity, and
enhanced understanding of studied phenomena (Bekhet & Zauszniewski, 2012; Basurto
& Speer, 2012; Yin, 2014).
I adopted multiple threat mitigation strategies such as sending interview
transcripts to each interviewee for correction (i.e., member checking), data triangulation,
detailed documented steps of data collection, processing, and analysis (Duc, Mockus,
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Hackbarth, & Palframan, 2014; Harper & Cole, 2012; Lincoln & Guba, 2011). Using data
triangulation of source, I used the same interview protocol (see Appendix C) throughout
the study to ensure the consistency of the semistructured interviews. Using data
triangulation, I identified themes from multiple data sources, that aided in the assessment,
interpretation, and conclusion of the information collected.
Qualitative data analysis is essentially about detection and the task of defining,
categorizing, theorizing, explaining, exploring, and mapping (Duc et al., 2014; Harper &
Cole, 2012; Ritchie & Spencer, 2002). The first step in the analysis is the design phase,
which defines the context of the analysis and identifies what needs to be known but is not
directly observable. The design phase specifies the empirical procedures for analysis and
the conditions that make the inferences based on the data. Data are collected from the
responses of participants to open-ended questions to gain insights and to answer the
overarching research question posed in this study (Bhattacharya et al., 2014; Cox, 2012;
Tufford & Newman, 2012).
The second stage defined the units of analysis, which makes it possible to draw a
statistically representative sample from the available data. Member checking served as a
tool to increase the accuracy and credibility of the data. The third step is sampling, which
facilitated the reduction of biases inherent in the type of data collected.
The fourth step codes the gathered data and classifies them into themes.
Researchers use text coding to categorize the data into key themes (Yin, 2014). Coding
and categorization allow the researcher to classify, sort and arrange the information in the
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most efficient, uniform manner (Basurto & Speer, 2012; Cassell & Symon, 2011;
Wahyuni, 2012). I assigned random codes to each participant to preserve the
confidentiality and to make it easier to organize and classify the data.
The fifth step necessitates the drawing of inferences, which is the most crucial
phase in content analysis. During this step, the analyst determines the relationship of the
accounts of coded data to the phenomena under investigation and produces new ideas,
theories, or strategies. The last step involves the validation of the data and the
development of the inferences based on the data. Krippendorff (2013) asserted that the
content analysis is used to infer what is not directly observable.
The features and capabilities of the NVivo 10.0 software are useful in achieving
organization, modeling, and understanding of the unstructured information (Ellegood,
2014; QSR International, 2015; Sapp, 2014). I encoded the transcribed data in the NVivo
10.0 tool to prepare for data analysis. NVivo 10.0 is a qualitative data analysis software
used to identify themes and similar responses from participants. I used the Krippendorff
method of content analysis to process the data. According to Krippendorff (2013),
content analysis can be used to generate inferences from large bodies of data that reveal
trends, patterns, and differences. Content analysis allows the objective treatment of
qualitative data regardless of the bias of the content analyst.
Throughout the data analysis, careful consideration for design, analysis, approach,
and processes assisted me to ensure the study results are reliable and valid. Goldratt
(1990) TOC framework was used to attain the organizational performance. TOC
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framework is designed to facilitate a systematic analysis within the demands of
constraints. The TOC framework provided a useful basis for this study because it
encourages business managers in the healthcare industry to identify solutions to reduce
the high costs associated with SCM.
Based on data analysis and emerging trends, I focused on the key themes related
to the organizational performance and compare them with the literature, inclusive of
newly published studies, as well as the conceptual framework used in this study. The use
of NVivo 10.0 was helpful in discovering subtle connections in collected data that could
be missed in manually analyzed data. In addition, NVivo 10.0 supports the rigorousness
needed to justify the research findings with the original data that support the finding
(Ellegood, 2014; QSR International, 2015; Sapp, 2014).
Reliability and Validity
From a qualitative perspective, the validity of a research study’s data will be
enhanced when the researcher establishes trustworthiness (Corbin, 2014; Hays & Singh,
2012; Merriam, 2014). With this in mind, the researcher attempts to achieve objectivity,
validity, and reliability of the study as much as possible.
Reliability
One of the major concerns of research studies is to maintain reliability and
trustworthiness throughout the research. Facilitating reliability in qualitative research can
be demanding because of the underlying concerns associated with its consistency
(Corbin, 2014; Hays & Singh, 2012; Merriam, 2014). I collected data from interviews
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and explicitly describe the role of the researcher to the interview participants. An
interview protocol (see Appendix C) served as the secondary instrument throughout the
interviews with all participants. Using the same guide with the same questions in
consecutive order assisted me to establish and ensure the consistency of the
semistructured interviews.
Merriam (2014) identified several relevant strategies in describing the reliability,
dependability, and audibility of qualitative research. Lincoln and Guba (2011) suggested
the notion of dependability as an alternative criterion for judging the reliability and
trustworthiness of qualitative research. The reliability of this research study included an
in-depth description of the processes for data collection, analysis, and interpretation.
Dependability requires the researcher to consider the constant changes within the
context of which the research occurs. Dependability is not measurable and needs to be
established using other qualitative means, such as member checking and triangulation
(Duc et al., 2014; Harper & Cole, 2012; Lincoln & Guba, 2011). I included the member
checking and triangulation in this study to provide the interviewees with the opportunity
to clarify the interpretation and possibly furnish supplemental perspectives on the study.
Quality control measures, including member checking, pilot testing, and transcript
review, can ensure a more accurate and unbiased study (Lincoln & Guba, 2011; Merriam,
2014; Yin, 2014).
Merriam (2014) suggested that a researcher (a) use clear research questions, (b)
explicitly describe the researcher's role, (c) ensure meaningful findings paralleling data
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sources, (d) connect reliability to theory, (e) broadly collect data, (f) perform data checks,
and (g) use peer review. Following the IRB guidelines maximized the protection of
human subjects and increased the reliability of the study processes and avoided potential
data corruption. Introducing bias, whether intentional or not, could negatively affect the
validity of the data.
Validity
The objective of the qualitative research is to present a perspective on the issue
and offer reports that reveal the researcher's capacity to describe the phenomena of
interest. Merriam (2014) suggested that internal validity, credibility, and authenticity is
realized when (a) research appears reasonably vicarious to readers, (b) triangulation of
data sources produce comparable conclusions, (c) data are connected to emerging theory,
and (d) conclusions are significant to informant. Data triangulation further supports and
enhances credibility (Duc et al., 2014; Harper & Cole, 2012; Lincoln & Guba, 2011). To
increase the credibility, I used the member checking and triangulation methods.
The external validity, transferability, and fittingness is realized when (a)
researchers use detailed description for readers, (b) findings are consistent with
experiences of participants, (c) the study supports further testing, and (d) the study is
easily replicated (Marshall & Rossman, 2011; Merriam, 2014; Yin, 2014). Transferability
refers to the degree to which the researcher can generalize or transfer qualitative research
results to other settings (Lincoln & Guba, 2011; Merriam, 2014; Yin, 2014). Marshall

72
and Rossman (2011) discussed that transferability should be left to the researcher
planning the next study.
Confirmability refers to the degree to which the results could be confirmed or
validated by others. Researchers should identify their biases at the outset of the study and
use the external audits to ensure validity (Lincoln & Guba, 2011; Merriam, 2014; Yin,
2014). NVivo 10.0 software is a proven qualitative tool to auto code and organizes data
(Leedy & Ormrod, 2013; Sapp, 2014; Yin, 2014). I used the NVivo 10.0 tool for
grouping the raw data into key themes. In this process, the tool assisted me to overcome
bias and researcher interests. This process served as the external validity of this study.
Data saturation occurs when no new data add to the findings or themes.
Triangulation of data sources, writing detailed-thick descriptions, and member checking
are reasonable, as well as time and cost-effective to facilitate (Denzin, 2012; Harper &
Cole, 2012; Walker & Jones, 2012). I used the following strategies to assure the data
saturation validity: (a) triangulation strategies, (b) peer review and debriefing, (c)
research bias clarifying, (d) member checking, (e) thick and descriptive writing, and (f)
external audits.
Transition and Summary
I used a qualitative case study design to achieve the purpose of the study, which
was to explore the SCM strategies that Indian business leaders in the healthcare industry
have used to reduce the high costs associated with SCM. I used a purposive sampling
technique to gather distribution professionals who could provide valuable insights for the
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study. I administered semistructured interview questions, composed of open-ended
questions to note the responses. Using Krippendorff's (2013) content analysis with the aid
of NVivo 10.0, I analyzed the responses of the participants. In addition, I used the
thematic categories and emergent themes identified to address the overarching research
question posed for this study. In Section 3, I reintroduced the purpose statement, provided
a brief summary of the findings in the introduction, discussed in detail the application of
the study to professional practice, presented the implications for social change, and
concluded the section with my recommendations for action and further research.
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Section 3: Application to Professional Practice and Implications for Change
Section 1 and 2 included an explanation of this study’s importance to business
leaders, as well as detailed information regarding the study’s design and implementation
procedures. This section includes: (a) overview of the study, (b) presentation of the
findings, (c) application to professional practice, (d) implications for social change, (e)
recommendations for action, (f) recommendations for further study, (g) reflections, and
(h) study conclusions.
Overview of Study
Supply chains prove critical to the success of pharmaceutical companies to
distribute medicine to suppliers and customers efficiently. The problem discussed in this
study was that Indian healthcare businesses spend large amounts of money on SCM
related factors and some Indian business leaders in the healthcare sector do not have the
required knowledge to implement the necessary best practices to bring down the high
costs of SCM. The purpose of this study was to find out what strategies some Indian
business leaders have used in the Indian healthcare context to reduce high costs by asking
the following overarching research question: What SCM strategies can Indian business
leaders in the healthcare industry use to reduce the high costs associated with SCM?
In this section, I present the summary of findings from conducting semistructured
qualitative interviews regarding the strategies that Indian business leaders in the
healthcare industry use to reduce the high costs associated with SCM. The findings show
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that Indian pharmaceutical companies face multiple distribution and logistics challenges
and lack the use of best strategies in SCM to reduce their overall cost.
Presentation of the Findings
I analyzed the qualitative data from semistructured interviews conducted with
three Indian business leaders in the pharmaceutical industry. The interviewees were
Indian business leaders working in pharmaceutical companies, willing to answer
questions about SCM strategies used to reduce the high costs associated with SCM.
The context of the data was qualitative research about the Indian pharmaceutical
industry, the money spent on SCM, and any related factors. The overarching research
question asked was as follows: What SCM strategies can Indian healthcare business
owners use to reduce the high costs related to SCM? The focus of this study was
supported by eight interview questions, as participants’ answers to these questions helped
to answer the overarching research question. The main inferences were what makes SCM
costs high in India and what strategies existed to help mitigate these costs.
I used the purposive sampling technique to select the study participants to answer
the interview questions. Choosing this method of sampling ensured that the small number
of cases yielded the right amount of information about SCM strategies. The target
population included business leaders, managers, and professionals performing the same
function for at least two years and working in pharmaceutical companies in India. The
first set of interviews captured the necessary detailed data for coding and analysis.
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I conducted the interviews using Skype and recorded each interview. I later
transcribed participants’ recorded answers for analysis and checked these for accuracy by
making them available to each interviewee. Each interview took about 30 minutes to
conduct and the consistency and nature of the questions provided the necessary
information and adequate responses needed for the study. I chose a Skype interview as
the method for data collection because it offered the ability to reach and observe the best
and most relevant participants. This was important for the study because these business
leaders resided overseas. Potential data loss by missing social and nonverbal cues, often
missed in standard telephone interviews, was mitigated by the use of Skype (Hancock &
Algozzine, 2011; Rohde et al., 2014; White et al., 2014). In addition, I received the
companies’ best practices and processes documentation from the participants. These three
sources of data allowed me to perform data triangulation during data analysis.
I maintained the anonymity of participants by assigning the coded sequential
representation of the participants’ name (e.g., ‘respondent 1’) on the copy of the consent
form and applying fictitious names to any discussed people. I did not share any
identifiable data anywhere in the analysis and write-up. I am the only individual with
access to the participants’ personal information and I kept the information safe in a
password-protected computer and locked cabinet. All data were stored according to the
correct procedures and will be destroyed after five years, according to University
requirements. I also adhered to the basic code of conduct, as planned and outlined by the
Belmont Report (Cugini, 2015).
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I downloaded the transcripts into NVivo 10.0 and completed a preliminary word
frequency search in the program. I have limited the frequency to the 25 most frequently
used words in the three coded interviews with a minimum length of at least five
characters. Table 1 below displays the top words, length, count, and the weighted
percentage in each of the interviews.
Table 1
Preliminary Word Frequency
Word

Length

Count

%

interviewer

11

59

2.08

interviewee

11

58

2.04

distribution

12

48

1.69

challenges

10

44

1.55

thank

5

43

1.51

organization

12

36

1.27

medicine

8

35

1.23

market

6

31

1.09

India

5

30

1.06

process

7

23

0.81

company

7

21

0.74

challenge

9

20

0.70

think

5

18

0.63

another

7

16

0.56
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different

9

16

0.56

supply chain

5

15

0.53

contingency

11

15

0.53

definitely

10

15

0.53

demand

6

14

0.49

transportation

14

14

0.49

based

5

13

0.46

global

6

13

0.46

infrastructure

14

13

0.46

question

8

13

0.46

supply

6

13

0.46

Table 1. Revealed the top words, length, count, and the weighted
percentage in each of the interviews

The initial step began with categorizing and building up the inferences with the
data. This first step offered the best way for starting the coding and comparing data
during each phase of the analysis. After completing the initial word frequency, I reviewed
the linked statements in the interviews for any relevant data. I have eliminated the top
two words from the list because these included the words interviewer and interviewee.
These words held no relevance to the analysis, as they were only part of the transcripts. I
used my best judgment to narrow down the list and incorporate words with a reference
count of 20 or higher to include in the first level analysis. A scan of the other words with
fewer references showed inclusion with several of the top words listed in the frequency;
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the assumption was that these words would be included in the nodes created from the top
words. The top words were distribution, challenges, organization, medicine, market,
India, process, company, and challenge. From these top words, I have decided upon the
most relevant ones from the list, which included challenges, market, organizations, and
process. I then created the preliminary nodes (i.e., categories) in NVivo 10.0 and found
patterns and themes in the interview data.
The next coding step involved creating individual nodes for the interview
questions. The interview questions included the following:
1. What is the process of medicine distribution in India?
2. What are the factors that contribute to the challenges of distributing medicine in
India?
3. What are logistic challenges encountered in distributing medicines in India?
4. What is the impact of distribution disruptions and logistic challenges to the
healthcare companies in India?
5. Do you think business leaders are spending considerable money in SCM related
factors? Why or why not?
6. How can the SCM process reduce the costs of medicine in India?
7. What type of SCM practices are in place for distributing medicines in India?
8. What are the primary logistical challenges faced by medicine distributors in
India? Such as long distance travel of the medicines?
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I used the interview question nodes for comparison with the coding created by the
word frequency. A comparison of this information led to the second level of coding and
organization of the coded interviews into three themes, including (1) distribution and
logistics challenges, (2) impact of SCM processes, and (3) best practices and solutions.
Figures 3-6 shown below depict the coding by item and the percentage of coverage
within each interview.

Figure 3. Distribution challenges - coding by item
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Figure 4. Logistics challenges - coding by item

Figure 5. Impact - coding by item
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Figure 6. Solutions and best practices - coding by item
These themes emerged from cross-referencing the interview data and are all
related to the organizational performance of healthcare companies. The themes revealed
information that assisted me in answering the overarching research question of this study.
I compared these themes with the literature on the subject and the TOC (Goldratt,
1990), which is the conceptual framework I selected for this study. The narratives
showed the overlap between all three interviewees’ responses. The narrative noted, with a
specific citation, whenever distinctions existed in opinion or whenever direct quotations
or paraphrases came from an interviewee. The narrative denoted these distinctions with
the categorization of R01, R02, or R03.
Theme 1: Distribution and Logistics Challenges

83
Distribution and logistics challenges in the supply chain system create a serious
problem for healthcare companies attempting to supply medications. All three
interviewees noted that these challenges center on the split nature of the supply chain
system. Figures 3 and 4 above reveal the percentage of coverage within each interview
related to the distribution and logistics challenges. Respondent 1 indicated that the main
factors or challenges for distribution of medicine in India are due to the highly
fragmented nature of the distribution network in the developing countries and, secondly,
to the different requirements for the transportation of drugs, such as a cold chain and
augment system.
Each product has its own transportation needs. This finding concurs with the
literature on the changes experienced in pharmaceutical supply chains over the past
several years (Kelle et al., 2012). Each interviewee also noted that fragmentation and an
overall distribution problem exists in developing countries for special transportation
requirements of the medicine within the supply chain network. Supply chains in both
developing and developed countries vary in regards to function, financing, and
performance (Choi et al., 2012).
This fact means that each step in the distribution and logistics process includes a
different player and requirement, creating additional problems because medications all
have their own transportation needs. The cold chain is a system of transporting and
storing medicine within a recommended temperature range. This cold chain and the
supplement systems need adjustment for each one of those products. Respondent 2 stated
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that every product manufactured requires various transportation parameters, such as
temperature and storage conditions, which represent major challenges faced by Indian
pharmaceutical leaders. Not every company was even aware of the transportation
requirements, which led to waste.
Each interviewee also described companies as different and complex in size and
needs. The company’s size contributed to the difficulty and/or the effectiveness of the
distribution throughout a network. “There are several challenges based on the
organization’s distribution size, especially related to distributing medicine in rural areas”
(R02). As noted, that was particularly true within the context of distribution to rural
areas, which is a significant factor throughout India. Typically, supply chains in
developing countries demonstrate serious weaknesses and difficulty in alignment because
of area conditions (Zhu et al., 2012).
Unlike in developed countries, we have a lot of infrastructural and communication
challenges in India.” Demand comes from various avenues and to meet this
demand promptly, especially in the rural areas, is a challenge. For example, in
cold chain requirements, infrastructure is not adequate to support the needs.
Another dimension is tax laws. We need to pay the intra-state transfer sales tax,
which is costing the company. Therefore, we have to invest in local distribution
networks and maintain them, which is another cost/challenge. It is even harder for
smaller companies not being able to afford the maintenance of these conditions,
as they are a tall order on their capital cost. (R01)
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Each interviewee reiterated this problem in the discussion regarding how rural
conditions and complexities within different areas of India affect medicine distribution
throughout the country. These conditions varied from climate conditions to company
authority and connected back to other problems associated with the conditions where the
medicine is transported and stored.
The most frequently mentioned challenges to both distribution and logistics were
transportation, infrastructure, and communication at each level of the supply chain. This
chain is outlined in Figure 7 below.

Figure 7. Supply chain outline
Supply begins the SCM process and goes through procurement, production,
storage, and distribution, stopping with the consumer and ending with the end user of the
products. These challenges actually play a part at each stage, not just with distribution.
According to Gjerdrum et al. (2012), the standard approach for testing the efficiency of
the supply chain distribution involves looking at all of its physical and business
processes. The interviewees revealed the difficulties facing most healthcare companies in
India because these processes showed flaws. This means that the basic reliability of the
entire supply chain remains in flux, posing an incredible risk and high cost of distributing
medicine to the market.
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Communication was a key issue at every stage of the SCM process, as poor
communication throughout the supply chain posed a serious risk, especially during
logistics and distribution. Communication becomes a major issue, particularly when the
medication left at the distribution center and transported by the moving company, did not
fall under the company’s control (R03).
Regarding communication once the drug leaves the facility to a fleet, there is no
way through which we can gain any kind of control over that fleet; so, we don’t
know where the drug is at any point in time. There's no way to track it. So, from a
communication perspective, that’s a tremendous challenge for us. (R03)
Respondent 3 indicated that the company’s leaders are unable to track the drug
shipment and, therefore, they cannot control shipment and delivery problems. This
finding links back to the discussion about other SCM challenges including overall storage
and transportation. Transportation is the most crucial aspect of the supply chain process
for both distribution and logistics, as determined by other researchers (Tsao & Lu, 2012).
Each participant noted that medication required specifically controlled temperatures and
conditions for shipment purposes. Medicine needs to be shipped by a particular
temperature controlled transportation, which leads to additional layers of complication
for distribution.
Complications emerged when communication was difficult or absent. Companies
needed reliable transportation partners able to understand the distribution challenges and
needs of the product. This is the reason communication was such an important factor in
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the whole process and it remained an ongoing problem for product distribution
throughout India.
Logistics challenges existed within the distribution problems and interview data
revealed contingency planning (e.g., optimum inventory levels), risk mitigation, global
expansion, fleet management, and communication as ongoing considerations. All the
interviewees noted that the problems with distributions and disruptions affected the
healthcare companies negatively. When medications are not distributed correctly or in a
timely manner, patients suffer and companies bear the burden of financial loss
(Uthayakumar & Priyan, 2013). These difficulties showed perpetuation because
companies worked within a constantly changing market, especially in India, as
companies must plan for emerging markets and new opportunities for distribution.
Interviewees noted that new opportunities introduced new problems requiring
proper handling to meet the demand and the need for risk reduction. Contingency
planning showed a fundamental necessity, as companies must have medication always on
hand to meet the needs of the existing market. Inventory management was a problem for
every company because each one must understand the optimum level of materials
required to produce finished goods for the market.
Uthayakumar and Priyan (2013) noted that without the right amount of medicine
in stock or not distributed promptly led to waste. All the interviewees reiterated that stock
must always be on hand, but only the right amount. Too much product means a reduction
in capital if supply outweighs demand. The requirement for each company varies on its
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own optimum level and the market size. Respondent 3 indicated that each company
builds a contingency plan for the optimum levels and, for a company in India, they
maintain 30% on hand, depending on the manager’s decision.
While careful contingency planning was necessary to meet the demand, poor
logistics either helped or harmed the stock. The interviewees brought up the issue of
reliable transportation again, as it was considered necessary for keeping stocks refreshed
and at optimum levels in distribution centers. This finding is also connected to
distribution challenges because India has over 30 states with varied climates, conditions,
and governmental regulations that needed handling.
Bhattacharya et al. (2014) reiterated the importance of the logistics supply chain
and the control of the flow of goods to meet consumer demand. The interviewees echoed
this importance when noting that a missing link in the supply chain meant problems for
distribution. The challenge of logistics meant that without quality processes in place,
companies had to delay fulfillments in the absence of effective communication between
distributors and their fleet operators. Each interviewee discussed the requirement that
companies need to invest in improving their SCM capabilities and the overall process to
mitigate contingency issues and negotiate the right levels of procurement with partners.
Ramanathan (2012) noted that contingency planning required careful consideration, as
most companies have a particular stock made to order and delays in procurement
occurred when companies did not account for the necessary stock levels.
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Procurement and the logistics of moving medicine included dealing with existing
regulatory mechanisms. Different laws in India determine the movement and selling of
medicine throughout the country and present challenges for SCM (Rohit et al., 2012).
The government controls the price of drugs and the national government employs a
number of policies regarding drug prices for various types of medication (Berndt &
Cockburn, 2014).
All of the interviewers touched upon this issue, noting that companies must deal
with government policies, including intrastate taxes for transferring and distributing the
products. Costs for taxation and movement end up being the financial responsibility of
the companies that need to build these costs into the overall cost structure of SCM. All
interviewees indicated that some of the Indian healthcare companies are investing in local
infrastructure and networks to reduce these costs. Berndt and Cockburn (2014) argued
that much of the necessary equipment and human resources for manufacturing existed
locally. This finding matched this study’s finding about reducing costs by trying out this
type of investment. However, finding and maintaining these connections represents an
additional and unique challenge.
Each of the interviewees stated that global markets for medication continue rising
in India and contribute to the logistics and distribution challenges. Respondent 1 reported
that global expansion is another challenge. While the global market provided an outlet for
new markets and potential revenue, growth required companies to spend more on SCM
processes for improved logistics quality. Distribution disruptions and stock shortages
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occur regularly. These problems relate to coordination and communication at each point
in the supply chain. Companies’ leaders learned to deal with the challenges, as some of
them were more common than others, so companies’ leaders work to mitigate the risks
represented by each challenge.
Furthermore, challenges related to contingency planning and maintaining stock
reserves at optimum levels need to be addressed to overcome disruptions and ensure
stock remained available at distribution centers, both locally and globally. This was
particularly important for companies distributing products in the market at all levels.
Each interviewee claimed that challenges linked to unreliable transportation and unstable
infrastructure remains constant.
The geographic location and diversity within the country create multiple unique
challenges for each healthcare company. The participants pointed out that logistics and
distribution must be connected components to obtain the successful release of medicine.
These challenges also relate to the supply chain aspect of fleet management. The rise in
pharmaceutical space around India and the opening of new pharmacies also create
another aspect of the market where fleets distribute the medicine to new areas open for
business. New fleets mean new partners, but a company needs to find reliable partners to
transport the medicine. Some companies found successful partnerships and helped
identify partners, depending on the geographic location.
Theme 2: Impact of SCM Processes
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According to the study participants, the most notable SCM challenge is related to
the logistics and distribution of medicine to the overall market. Each company uses
similar methods to overcome these challenges, including distribution problems, stock
shortages, and disruptions in the delivery at the local level. Figure 5 above displays the
percentage of coverage within each interview related to the impact of SCM processes.
Companies planned for any new growth, but they needed to cater to the existing
market at the same time. This issue requires companies to be ready with those strategies,
outlined by the distribution and logistics challenges; including contingency planning, risk
mitigation planning, and ensuring medicine remained available to meet the demand for
expansion into new and existing markets.
Qiang and Nagurney (2012) supported these ideas by noting that any number of
issues ranging from customs inspections to lack of capacity in the transportation network
impacted companies. Bueno-Solano & Cedillo-Campos (2014) also pointed out that
supply chain issues include lack of stock, production problems, and delivery of products
to consumers. This study’s participants discussed the challenges of logistics and
distribution, which included inadequate processes and increased capital spending on
improvements. These challenges led to poor communication and fulfillment delays for
medicine.
Respondent 1 stated that "many fulfillments are getting delayed due to the lack of
effective communication. By investing in improving our capabilities, we not only reduce
the costs but also enhance the quality of the overall process." The emergence of new

92
markets also influences the cost of medicine on the market, representing either a burden
or a source of new revenue. Companies had to make sure that they improve their
processes sufficiently well to meet the new demand. It also meant companies had to
invest and secure needed capital to meet the evolving market needs. The biggest impact
from these challenges is that more money needs to be invested in SCM processes and
related factors.
Deshpande (2012) noted that companies reached better organizational
performance levels when they achieved projected organizational and financial goals.
Companies need to invest in new markets while continuously serving the current market
needs. The minimum stock is necessary for every pharmacy and retail store on the market
to ensure medicine availability. Respondent 3 claimed that "when it comes to existing
markets, we need to make sure that we have the minimum stock availability for every
pharmacy or every retail store." This means that pharmaceutical leaders must first
overcome the logistics and distribution challenges to meet that demand. The right
contingency plans are critical to ensuring the availability of medicine. As a result, the
impact that entering the new market has on business organizations is highly difficult to
handle because it is challenging to maintain the existing stock of the current market,
which also raises the contingency numbers. Not having decent infrastructure or
communication companies would lose revenue and a share of the market.
Theme 3: Solutions and Best Practices for SCM
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Barney (2012) suggested that an organization gains a competitive advantage when
it creates a firm position for itself within the market and one that differentiates itself from
the competition. Goldratt’s (1990) TOC served as a framework for the responses of the
three interviewees, providing similar best practices for reducing company costs and
increasing capabilities. TOC offers three areas covering logistics, performance
measurement, and logical thought (Cox & Spencer, 1997). This framework is useful to
business managers to understand the kinds of things that keep a company from achieving
best practice goals and to identify any problems. The point of the TOC is to help
companies’ leaders find the best ways to maximize their performance and to evaluate
organizational performance based upon goods, inventory, and operating expenses (Gupta
& Anderson, 2012).
From this study’s participant responses, best practices emerged, covering the
continued or increased investment in building up a good SCM structure and processes,
introducing cost saving measures, implementing forecasting models and watching the
market for changes, and encouraging movement into new markets but spending the
necessary capital for improving and modernizing the whole system. Enhancements to the
supply chain process occurred when companies introduced cost saving measures through
automation and improved communication. These improvements are important factors for
reducing waste and unnecessary inventory. An identified need emerged to create
partnerships locally, regionally, and globally to build trust and to keep medicine costs
down.
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Goldratt’s (1990) TOC noted that performance improves when organizations find
ways to improve productivity while keeping operational and inventory expenses in check.
Participants repeated the claim that existing best practice for SCM includes the rolling
forecast models for emerging and existing markets. Forecast models exist when a
company uses baseline data to calculate future product demand. Acar and Gardner (2012)
described forecast models as the means of reducing uncertainty in areas of distribution
and logistics planning for SCM. Stock and Watson (2012) noted that forecasting methods
include several categories for forecasting, requiring forecaster’s personal judgment and
quantitative data. The participants said that such models need constant refinement to keep
the system up-to-date and to make projections for the appropriate market conditions.
Improving technology, building infrastructure, and applying updated forecasting models
are necessary to reduce the overall supply chain cost. This finding was similar to the
improvement of efficiency processes made achievable by the TOC methodology.
Efficiency is perhaps the most important best practice a company can achieve (Rhee et
al., 2010).
The company’s size and market determine the forecast and constant refinement of
the forecasting models is a necessary best practice. This finding is consistent with the
work of Stock and Watson (2012), as they argued that forecasting methods have to be
different depending upon the product and company context. Bazzani and Canavari (2013)
also noted that external factors influenced market size and demand, including
demographics. The interviewees reiterated these points by saying that sources of demand
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mattered. Respondent 2 claimed that demand sources include governmental organizations
and public and private firms. The important factor is to ensure that the company's model
fits its size and that it remains consistent. Graefe et al. (2014) showed that combining
forecasting models and methods are reduced error. The participants also confirmed that
multiple types of models are required to distribute the medicines, and constant refinement
is necessary to accommodate the market conditions.
In addition to the forecasting models, companies’ leaders also use replenishment
tactics to address the contingency planning. Efficient SCM process reduces the cost of
medicine, by building infrastructure capabilities, managing the cold chain supply,
engaging in market forecasting, and improving product contingency measures. Such
tactics regulate expired drugs, reduce waste products, and ensure patients received the
medicine on time. Waste management is a critical component of an organization because
excess products are a drain on the company revenue. Haq and Boddu (2015) noted that
while collaborative planning needs the support of tools and multisite planning, it depends
on proper coordination and good management.
Study participants claimed that good management requires having the right
trading partner to source the raw materials and to destroy timely expired products for
reducing the overall costs. Nagurney et al. (2013) showed that a good management
system within the SCM process provides optimal product flow and improved efficiency.
This finding matched the interviewees’ opinions that the entire SCM process, from the
supplier to the end user, is required for best practices and problem solutions. Efficient
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SCM improves the overall operational efficiency of a company by capturing new markets
quickly and expanding the company's profit margin. All the study participants noted that
the correct forecasting models and efficient SCM processes might make the difference in
organizational negotiations and cost savings for a healthcare company.
Another area of improvement in best practices is in process management. Study
participants claimed that many organizations are running the manual process for
procurement and administration functions. Simatupang et al. (2004) noted that when
using the TOC method, organizations can overcome the challenges associated with
collaboration and replenishment policies. Working together to establish better process
management and communication improvement advances the profitability of an
organization (Simatupang et al., 2004). Building relationships and securing appropriate
trading partners in new markets is an essential requirement for a company.
Transportation and infrastructure continually appeared as key components of the
best practices given by study participants. Chan & Zhang (2011) reported that
transportation is the connecting point between all aspects of the supply chain. Participants
voiced that companies need a strong infrastructure to thrive in a changing market and,
having their own transportation fleets or a reliable partner to make on time deliveries,
ensures product availability all the time. Respondent 2 claimed that by owning the
transportation capabilities, an organization can overcome the on-time delivery challenges
associated with medicine distribution to the customers.
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Indian business leaders in the healthcare industry spend money to improve the
process and solve SCM issues. This practice of spending money to improve the SCM
process is a change from previous decades (Christopher & Holweg, 2011). However, the
previous system changed because companies needed better strategies to support their
long-term transportation needs and to handle their transportation costs in SCM (Prajogo
& Olhager, 2012).
Most organizations are spending money on transportation because it improves the
system and increases revenue. Respondent 3 stated that approximately 30% of the
business organization’s revenue is placed back into supply chain improvements. Best
practices always include being ready to evolve as the market continually changes.
Forecasting is required, because what happened a few years ago is no longer relevant.
Also, it is necessary to look at the overall supply chain process and find areas for
improvement. Respondents commented that companies always had to be on the lookout
for new markets and partners for trade.
TOC provides a useful basis for this study because it encourages business
managers in the healthcare industry to identify challenges associated with SCM strategies
and to find solutions to improve efficiency. The interviewees considered that
replenishment and forecasting models are important parts of managing both, existing and
new markets. Forecasting and replenishment methods are industry standards for the
majority of healthcare companies. However, there was an outlier in one of the interviews
regarding forecasting. Study respondent 3 indicated that Indian business leaders are
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considering the e-commerce business as a new method for distributing the medicines.
Also, respondent 3 claimed that e-commerce infrastructure enables the supply chain
partners to share data quickly and to build trust and visibility. While traditional models
are excellent, the e-commerce model helps to change and improve the market by
lowering costs and improving effectiveness that translates into revenue for a company.
Companies need to spend money to make necessary changes and improve
processes. Respondent 2 stated that to stay ahead of the market demand and to reduce the
long term operational costs, Indian business leaders in the healthcare industry spend more
money on SCM processes. Organizations investing money in making improvements to
their SCM processes have experienced better financial outcomes. Companies have even
shifted away from offshoring certain parts of the supply chain process to near-shoring, as
a means for reducing costs (Ellram et al., 2013). This action was part of the overall
solution given by this study participants to finding resources closer to home to help cut
expenses in the market. Essentially, a company reduces operating costs and increases
revenue by uncovering and satisfying unmet needs in the market. Investing and
constantly refining the SCM processes are the main components of best practices and
solutions to SCM process problems.
Applications to Professional Practice
Adhikary and Bora (2014) pointed out that SCM costs in India are incredibly high
in comparison to other parts of the world and they account for 13% of the country’s GDP.
These high costs associated with SCM make the findings from this study applicable to
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professional practice in the healthcare business. Supply chain managers in healthcare
companies can apply the best-practice results from this study to create and deliver better
services in SCM. Improved services will increase the company’s reliability, product
availability, and delivery of the right products for existing and emerging markets. These
findings include the continued or increased investment in building up a better SCM
structure and the introduction of cost-saving measures, such as contingency planning and
risk mitigation. Also, the findings from this study may assist companies’ leaders in
implementing the right forecasting models, encourage movement into new markets, and
spend the necessary capital for improving and modernizing the whole SCM system.
Using the right tools presented by these findings provides improved visibility on
company performance, helps improve costs, and decreases supply disruptions.
This study’s findings show that challenges to logistics and distribution continue to
rise in India. Global market demands are increasing within the Indian healthcare industry,
as demand for products increases. The interviewees also reiterated that companies need to
invest in improving the SCM process to meet the existing and emerging market needs.
That means both coordination and communication have to improve and must address
these issues at every point in the supply chain. Disruptions and shortages are common,
but the experiences noted in the findings apply directly to how healthcare companies can
improve the quality of their distribution and logistics. Healthcare organizations should be
investing in the improvement process by using the proven strategies for contingency
planning and risk mitigation.
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Supply chain failures occur all across the supply chain model in different ways. It
is critical that Indian business leaders in the SCM area select the right strategy to reduce
risk. They should use the most practical approach presented to meet the numerous
disruptions taking place in a particular market. Implementing the information from this
finding can minimize the risks, increase effectiveness, and maximize the allocation of
resources. This is particularly important because of the geographic diversity of India
which creates unique challenges for each healthcare company.
Goldratt’s (1990) TOC provided a useful basis for this study because it
encourages business managers in the healthcare industry to identify challenges associated
with SCM strategies and to find solutions to overcome this hindrance. As suggested by
Goldratt and Cox (1990), companies should focus on identifying constraints and
understanding how to explore the identified constraints to return to usual practices. The
findings from this study suggest that companies will see efficiency by implementing the
best practices to improve the overall SCM model. Efficiency is the most important aspect
a business can achieve (Rhee et al., 2010).
Companies’ leaders need to understand their entire supply chain and to implement
collaboration among distribution partners to take advantage of its benefits (Saberi et al.,
2012). Any lack of awareness about the supply chain process holds a business back. For a
healthcare company to be competitive in the Indian and the global market, it must adopt
the right strategies to respond quickly and efficiently to the supply chain disruptions
(Simatupang et al., 2004).
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Implications for Social Change
In terms of social change, this study is significant because its findings may assist
the Indian healthcare companies and those working in the field of medicine distribution,
in making the essential medicine available to the consumers without disruption. This
study’s results may impact the availability of medicine to the end users in the healthcare
market both in the Indian and the global markets. India offers low-cost drugs to its
citizens and other patients from around the world (Berndt & Cockburn, 2014). Using the
information from these findings may help companies’s leaders build plans to address
weaknesses in the supply chain and to ensure that products reach consumers on time.
Kelle et al. (2012) noted that the pharmaceutical industry has undergone
numerous changes over the years and it has developed a new role in the business
industry. Supply chain managers should work with other supply chain partners to
minimize the disruptions in the supply chain, thereby ensuring essential medicines will
continue to move through the supply chain processes and, ultimately, reach the end
consumer. The findings from this study could provide a basis for supply chain managers
to develop and implement supply chain disruption strategies that could minimize the
negative effects disruptions have on their organization’s profitability and performance.
Managers have the opportunity to minimize unfavorable outcomes and supply
chain disruptions by implementing best practices and strategizing them carefully.
Improvements in healthcare industry SCM processes mean overall improvements to an
individual’s personal health, the public health, economic health, and social well-being of
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people. The implications for positive social change include the potential of reducing
supply chain risk, which could lead to lower prices of products for consumers, increased
stakeholder satisfaction, and a higher standard of living.
Recommendations for Action
The findings from this study indicate that medicine distribution problems build
upon one another. Logistics and distribution challenges include forecasting and gaps in
the communication during the transportation. Business leaders need to consider every
aspect of the SCM process to realize its benefits. Developing a standard approach to
modeling and forecasting a company’s needs is critical to that organization because it
helps to incorporate all aspects of the SCM processes, including product development,
transportation, and storage (Gjerdrum et al., 2012).
Forecasting models vary, depending on the size of the business organization and
the market it serves. Interviewees noted that Indian healthcare companies are operating in
a fragmented market system. External factors constantly change the market’s size and
shape, requiring consideration when making projections about product needs and
distribution (Bazzani & Canavari, 2013). Companies continuously refine the process by
implementing new technologies as these become available. Forecasting methods are
excellent ways to strengthen business processes without being invasive to the supply
chain process (Gjerdrum et al., 2012).
According to Stock and Watson (2012), multiple methods exist for forecasting
depending on the product, company size, and the environment. The morbidity-based
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forecasting method allows the companies or products to forecast without prior data
(Vivas-Consuelo et al., 2014). Adjusted consumption-based forecasting is another
method used when no reliable data is available (Vivas-Consuelo et al., 2014).
Interviewees indicated that the combination of two forecasting methods offers a best
possible solution for healthcare companies in India.
The purpose of forecasting is to find potential business demand to ensure
managers can make accurate decisions about pricing, business growth, and market
potential (Acar & Gardner, 2012). Companies should build upon efficient SCM
processes, such as replenishment and forecasting, because it reduces the product cost and
excess inventory and improves contingency measures. According to Haq and Boddu
(2015), companies can improve the operational cost through collaborating in the supply
chain process and by reducing the supply cycle time.
Interviewees indicated that organizations need to consider improvements in the
supply chain process management. Several Indian healthcare companies are using a
manual process for logistics and procurement tasks. Although the traditional models do
work for some companies, the manual process is expensive and prone to error.
Respondent 3 stated that e-commerce is a management process that improves trust and
allows sharing data instantly among partners in the supply chain. The e-commerce model
fosters activity in the market, reduces operational cost, and helps to build upon other best
practices.
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Applying best practices to a company’s SCM process contributes to overcoming
supply-partners collaboration problems and increases profitability (Simatupang et al.,
2004). A company’s efficiency improves when organizations adopt shifting strategies
away from expensive transport supply chain strategies to efficient designs for
transportation (Khan et al., 2012). Companies should consider efficiency regarding their
products, including when, where, and how to store them properly. Transportation may be
an essential part of the supply strategy, as it connects each part of the network in the
supply chain system (Buyukkuaramikli, 2014).
Organizations need to move beyond their inner walls and implement new
collaborative strategies and process improvements to reduce costs for their companies
and to the consumers (Ellegood, 2014). Companies should also consider refining storage
and warehousing strategies as part of SCM best practices. Implementing a movement
towards a consolidated warehouse provides improved transport services for an
organization and logistics management (Hofmann & Lampe, 2013). Overall, the
healthcare companies require spending capital on technologies and best practices to
improve processes. The findings from this study support these recommendations from the
literature, as Respondent 2 claimed that the market demand requires companies to have
efficient forecasting models and capabilities to meet product levels, as this is the only
way to stay ahead in the rapidly changing market.
The findings from this study could apply to all healthcare companies across all
aspects of the SCM. Managers and business leaders in the field of medicine distribution
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and pharmaceuticals may benefit from the findings of this study. Organizational
performance is needed for companies to achieve their financial goals (Deshpande, 2012).
The findings from this study demonstrate that while the challenges represented by supply
chain problems and business performance are linked investment in best practices that
work within the Indian context are required. At present, managers and business leaders in
the healthcare industry share the essential information through professional networks.
The results of this study also contribute to supply chain discussions regarding
investment strategies and the SCM best practices for process improvements. Educating
companies on supply chain policies in the healthcare industry can influence other
organizations to apply necessary changes. Publishing the study in an approved research
database also provides access to researchers, students, and others interested SCM
professionals. Study participants will receive a copy of the summary and findings, which
will also add to dissemination efforts. Finally, I will publish this study’s findings in a
peer-reviewed journal and find opportunities to present the information at seminars and
conferences.
Recommendations for Further Study
This study provides the foundation for future research into understanding the best
strategies for managing supply chains. Future research can deepen the understanding of
issues facing Indian pharmaceutical companies and global healthcare companies. This
study’s findings show the relationships, strategies, and best practices employed by
managers and companies to mitigate medicine supply disruptions. An expansion of the
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case study to include the perspectives of other business leaders in India, and outside of
India, would serve to broaden the transferability of the research to other markets.
Limitations are potential shortcomings of the study that are typically out of the
researcher’s control (Marshall & Rossman, 2011). This study has limitations, as it only
refers to SCM strategy issues within India, although some of the information does have
applicability to all healthcare markets. In terms of recommendations for future research,
researchers should analyze the individual pieces of the overall SCM system and identify
optimal strategies for eliminating weaknesses within each part of the process. This
study’s sample provided rich information on the best practices employed by Indian
business leaders; however, the data are limited to their experiences and perspectives.
Including a broader group of participants from various organizations is highly
recommended.
It is beneficial to see the way companies use different forecasting methods and
confirm which ones do provide the best possible results for companies to adopt.
Researchers should also look into outcomes-related process changes and technologies
implemented within the healthcare industry to understand the manner these changes
contribute to the improvement of the supply chain process.
While this study offers a fresh perspective on current SCM strategies that indian
business leaders are using and provides recommendations for best practices, more
research is needed to find additional practices to overcome supply chain problems. A lack
of knowledge still exists about all of the best practices in SCM strategies and the best
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way to implement these within the industry. The costs associated with all aspects of the
healthcare industry’s SCM require increased consideration to improve decision-making
processes (Ellegood, 2014).
Reflections
The experience gained from this study allows me to recognize that numerous
considerations for implementing best practices in SCM do exist. All of the problems
discussed throughout the study are interconnected and is surprising when the data
revealed that challenges to distribution and logistics overlapped in many areas. At first, it
appeared to me as if the strategies focus on one supply chain area and, then, companies
could see improvements on overall SCM. However, it became apparent that all aspects of
the supply chain process need to be reviewed to have a robust discussion about effective
SCM strategies.
I was unbiased and focused throughout the study on business issues detailed in the
initial proposal. The three study participants were open to sharing their experiences and
insights and the interview method was successful in gathering data that later became
information. The interviewees provided an outstanding amount of data that assisted me in
answering the overarching research question for this study.
Initially, I did indicate that a quantitative and mixed research approach would not
be viable for this study and this claim still stands. However, the experience from
conducting this study shows that a mixed methods approach would only enhance the
results. The decision to use a purposive sample ended up being excellent because the
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participants provided a substantial amount of information. Finally, I found it inspiring to
listen to study participants recount their personal experiences. Moreover, it is personally a
fulfilling experience to add new insights to the body of literature on this topic.
Summary and Study Conclusions
Data analyses confirmed previous assumptions detailed in this study about SCM
strategies. The next step for furthering the implementation of best practices across the
Indian healthcare sector is identifying how often the best practices are used and who still
needs to learn about them in this industry. Companies that implement effective SCM
processes may see significant improvements in their supply chain outcomes and
efficiency arising for both the company and the consumer. The most important best
practices include reducing challenges to the distribution and logistics, implementing the
appropriate forecasting and replenishment techniques, and spending more on improving
processes and collaboration. In conclusion, leaders of healthcare companies should
continue using these strategies and expand them to reduce or eliminate weak areas of the
supply chain process to reduce costs in SCM.
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Appendix A: Consent Forms
You are invited to take part in a research study that focus on exploring the
perceptions and lived experiences of business leaders who have been successful in taking
advantage of the best practices and SCM knowledge in India. You are chosen for this
study because you are a business leader of an organization with overseeing the medicine
distribution responsibilities. This form is part of a process called “informed consent” to
allow you to understand this study before deciding whether to take part. This study is
being conducted by Prasad Bolineni, who is a doctoral student at Walden University.
Background Information
The purpose of this study is to understand the best practices and successful
strategies in place to reduce the costs associated with SCM.
Procedures
If you agree to be in this study, you will be asked to participate in a Skype
interview each session lasting no more than 30 minutes


Interview #1 will include a series of 8 open-ended questions



Interview #2 (optional) will be a follow-up opportunity for you to provide any
additional information you may have missed in interview #1

Voluntary Nature of the Study
This study is voluntary. Everyone will respect your decision of whether or not you
choose to be in the study. No one will penalize you if you decide not to be in the study. If
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you decide to join the study now, you can still change your mind later. You may stop at
any time.
Risks and Benefits of Being in the Study
Being in this study would not pose a risk to your safety or well-being as the study
focuses only on examining the lived experiences and perception of participants, and no
confidential information will be discussed. The potential benefits of being in the study is
your contribution to an enlighted view of strategies that business leaders use to reduce the
organization SCM costs.
Payment
No payments / compensation will be given to any participants in the study.
Privacy
Any information you provide will be kept confidential. The researcher will not
use your personal information for any purposes outside of this research project. In
addition, the researcher will not include your name or anything else that could identify
you in the study reports. Collected data will be secured in a locked cabinet, and I am the
only person who will have access to this data. Data will be kept for at least five years, as
required by the university.
Contacts and Questions
You may contact the researcher any time during and after the study execution via
email prasad.bolineni@waldenu.edu for any questions pertaining this study. If you want
to talk privately about your rights as a participant, you can contact Dr. Leilani Endicott
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via email irb@waldenu.edu or 1-800-925-3368, ext. 312-1210, who is the Walden
University representative for this study, can discuss with you. Walden University’s
approval number for this study is 11-10-15-0171351 and it expires on 09-Nov-2016. The
researcher, Prasad Bolineni will give you a copy of this form to keep.
Statement of Consent
I have read the above information and I feel I understand the study well enough to
make a decision about my involvement. By replying to this email with the words, “I
consent”, I understand that I am agreeing to the terms described above.
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Appendix B: Invitation to Participate in Business Research Form
In-Depth Interviews - Invitation to Participate in Business Research
Greetings Mr. or Mrs. XXX,
I am a doctoral student at Walden University pursuing a Doctorate of Business
Administration degree. You are invited to voluntarily take part in a research study that
focuses on exploring the perceptions and lived experiences of business leaders who have
been successful in taking advantage of the best practices and SCM knowledge in India.
The purpose of this study is to understand the best practices and successful strategies in
place to reduce the costs associated with SCM. The study conduct procedures include a
series of semistructured interviews. Your name or any other information that could
personally identify you will not be included in any reports of the study.
If you are interested in participating in the study, please refer to the attached
‘informed consent’ form. This document provides detailed information to help you
understand the study conduct procedures and better assist you in your own personal
decision whether to participate. Walden University’s approval number for this study is
11-10-15-0171351 and it expires on 09-Nov-2016. After reviewing the attached consent
form, if you are agreeable to participate in this research, please reply to this email with
the words “I consent.” By doing so, you are agreeing to participate voluntarily in the
study. Please feel free to e-mail me if you have any questions or would like additional
information. Please respond at your earliest convenience indicating your decision. I
sincerely appreciate your time.
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Appendix C: Interview Protocol Form
Project: Exploring the perception and lived experiences of the business leaders
best practices and successful strategies in place to reduce the costs associated with SCM.
Date: __________

Time: ____________ Location: __________________

Interviewer: ______________________

Interviewee: ______________________

Notes to interviewee:
1. The interview session will begin with greetings and introductions.
2. Remind the previously read and signed informed consent forms and thank for the
participation in the study.
3. I will share the signed informed consent hard copy to the participant for their records.
4. I will turn on the audio recorder and note the date, time, and location.
5. I will indicate the coded sequential representation of the participant’s name, e.g.,
‘respondent 1’ on the audio recording, documented on my copy of the consent form
and the interview will begin.
6. Each participant will be given the required time to fully answer each predetermined
interview question in detail (including any additional follow-ups / probing questions).
7. At the close of the interview, I will thank each research participant for their time and
participation in the study.

